STOCK TITAN

Once Upon a Farm recalls Tractor Wheels bars

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Once Upon a Farm, PBC (OFRM) reported third-quarter net sales of $89.067 million, up 35% from $66.036 million a year earlier; nine-month sales rose 40% to $247.179 million. Third-quarter net loss narrowed to $3.813 million from $11.255 million, while operating loss widened to $4.656 million from $1.052 million. Cash used in operating activities for the first nine months was $4.600 million, versus $23.236 million.

On October 30, 2026, the company announced a voluntary recall and reformulation of all Tractor Wheels soft-baked bars due to reported choking incidents and temporarily suspended shipments. Tractor Wheels represented approximately 18% of nine-month net sales; related inventory was approximately $7.9 million as of October 31, before adjustments for net realizable value or obsolescence. The company expects the recall to significantly affect fourth-quarter 2026 results and cash flows, potentially into later periods. It is preparing for a return to shelf after evaluation and any necessary product-safety changes are implemented and validated.

4 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 3 points

Hollow bars mark forward-looking points. How the balance works

Positive

  • Moderate pointThird-quarter net sales increased 35% to $89.067 million.
  • Moderate pointThird-quarter net loss narrowed to $3.813 million from $11.255 million.
  • Moderate pointNine-month operating cash use was $4.600 million, versus $23.236 million.
  • Minor pointNine-month net sales increased 40% to $247.179 million.

Negative

  • Moderate pointThird-quarter operating loss widened to $4.656 million from $1.052 million.
  • Moderate pointTractor Wheels represented approximately 18% of nine-month net sales; shipments were paused.
  • Moderate point. Forward-looking: it has not happened yet and may not happen.Recall expected to significantly affect fourth-quarter 2026 results and cash flows.

Filing Explained

At September 30, 2026, cash was $106,408 thousand with no borrowings, while $30.0 million and $58.2 million remained available under the separate facilities.

This unaudited quarterly report records the February 2026 IPO as completed. The company issued 9,281,118 IPO shares and received approximately $138.5 million net; its preferred stock and convertible notes converted into 21,779,817 and 2,819,512 common shares, respectively. Issuing additional shares increases the total share count and reduces existing holders’ percentage ownership, absent offsetting changes; Once Upon a Farm reported 42,244,588 common shares outstanding at September 30, 2026.

It used $43.0 million of IPO proceeds to repay prior borrowings; at September 30, 2026, it reported $106,408 thousand in cash, no outstanding borrowings, and availability of $30.0 million under its term-loan facility and $58.2 million under its revolving facility, not amounts already borrowed.

Third-quarter net sales $89.067 million Three months ended September 30, 2026; increased 35% year over year.
Nine-month net sales $247.179 million Nine months ended September 30, 2026; increased 40% year over year.
Third-quarter net loss $3.813 million loss Three months ended September 30, 2026, compared with $11.255 million in 2025.
Third-quarter operating loss $4.656 million loss Three months ended September 30, 2026, compared with $1.052 million in 2025.
Operating cash used $4.600 million Nine months ended September 30, 2026, compared with $23.236 million in 2025.
Tractor Wheels share of net sales Approximately 18% Nine months ended September 30, 2026.
Tractor Wheels inventory Approximately $7.9 million As of October 31, 2026, before adjustments for net realizable value or obsolescence.
nonrecognized subsequent event financial
"determined to be a nonrecognized subsequent event"
stock appreciation rights financial
"granted 694,835 stock appreciation rights under the 2021 Plan"
Stock appreciation rights (SARs) are a form of employee compensation that give the holder the right to receive the increase in a company's stock price over a set baseline, paid in cash or shares, without having to buy the stock. For investors, SARs matter because they can create future cash outflows or share dilution and signal how a company rewards and motivates executives — similar to giving a bonus tied directly to how well the company’s stock performs.
slotting fees financial
"trade spending ... includes ... slotting fees"
Black-Scholes option-pricing model technical
"using the Black-Scholes option-pricing model"
minimum purchase commitment financial
"remaining future minimum purchase commitment"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much revenue did OFRM report for the third quarter of 2026?

OFRM reported third-quarter net sales of $89.067 million, up 35% from $66.036 million in 2025.

What is OFRM recalling, and what must happen before the product returns to shelves?

OFRM temporarily suspended shipments of all Tractor Wheels soft-baked bars after announcing a voluntary recall and reformulation due to reported choking incidents. The company is preparing for a return to shelf after completing an evaluation and implementing and validating any necessary product-safety changes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false0001696556--12-31Q3http://fasb.org/us-gaap/2026#AccountingStandardsUpdate202505Memberhttp://onceuponafarmorganics.com/20260930#ConvertibleNotesMemberoneonehttp://fasb.org/srt/2026#ChiefExecutiveOfficerMember3553797761660001696556us-gaap:RelatedPartyMemberofrm:SpokespersonAgreementMember2026-01-012026-09-300001696556us-gaap:CommonStockMemberus-gaap:LineOfCreditMemberofrm:ConvertiblePreferredStockWarrantsMember2026-02-090001696556us-gaap:StockAppreciationRightsSARSMember2025-01-012025-12-3100016965562026-07-012026-09-300001696556us-gaap:StockAppreciationRightsSARSMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2025-07-012025-09-300001696556ofrm:ConvertiblePreferredStockWarrantsMember2026-01-012026-09-300001696556us-gaap:RestrictedStockUnitsRSUMember2025-07-012025-09-300001696556us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310001696556us-gaap:EmployeeStockOptionMember2026-01-012026-09-300001696556ofrm:KidPouchesMember2026-07-012026-09-300001696556us-gaap:AdditionalPaidInCapitalMember2025-12-310001696556ofrm:HarbingerVenturesLLCMember2026-09-300001696556ofrm:ConvertiblePreferredStockWarrantLiabilityMember2025-01-012025-09-300001696556us-gaap:RestrictedStockUnitsRSUMember2025-12-310001696556us-gaap:ConstructionInProgressMember2025-12-310001696556us-gaap:RelatedPartyMembersrt:MinimumMember2026-09-300001696556us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-09-300001696556us-gaap:StockAppreciationRightsSARSMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2025-01-012025-09-300001696556us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberofrm:CustomerDMember2025-01-012025-12-310001696556us-gaap:StockAppreciationRightsSARSMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2025-03-270001696556ofrm:SnackBarsOverFiveYearsMember2026-01-012026-09-300001696556us-gaap:CommonStockMember2026-09-300001696556us-gaap:ConvertiblePreferredStockMember2025-12-310001696556us-gaap:FairValueMeasurementsRecurringMemberofrm:ConvertiblePreferredStockWarrantLiabilityMember2025-12-310001696556us-gaap:RevolvingCreditFacilityMember2025-07-012025-09-300001696556us-gaap:CommonStockMemberus-gaap:IPOMember2026-02-090001696556ofrm:SnackBarsPerYearMember2026-01-012026-09-300001696556ofrm:CassandraCurtisMember2026-09-300001696556us-gaap:ConvertiblePreferredStockMemberofrm:TwoThousandAndTwentySeriesBOneWarrantMember2025-12-310001696556us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2025-09-300001696556us-gaap:RevolvingCreditFacilityMember2026-09-300001696556us-gaap:CommonStockMember2025-09-300001696556ofrm:KidsProductMember2025-01-012025-09-300001696556us-gaap:WarrantMember2025-01-012025-09-3000016965562026-11-080001696556us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2026-01-012026-09-300001696556us-gaap:RetainedEarningsMember2025-12-310001696556us-gaap:StockAppreciationRightsSARSMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2026-07-012026-09-300001696556us-gaap:ConvertiblePreferredStockMemberofrm:TwoThousandAndTwentyTwoSeriesDWarrantMember2025-12-310001696556us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberofrm:CustomerDMember2026-01-012026-09-300001696556us-gaap:RetainedEarningsMember2026-03-3100016965562026-09-300001696556ofrm:SingleReportingSegmentMember2026-01-012026-09-3000016965562025-07-012025-09-300001696556us-gaap:WarrantMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2025-01-012025-12-310001696556us-gaap:StockAppreciationRightsSARSMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2025-03-272025-03-270001696556ofrm:SeriesC-2ConvertiblePreferredStockMember2025-12-310001696556us-gaap:ConvertibleDebtSecuritiesMember2025-01-012025-09-300001696556us-gaap:ConvertibleDebtSecuritiesMember2025-07-012025-09-300001696556us-gaap:ConvertibleDebtSecuritiesMember2026-07-012026-09-300001696556us-gaap:RevolvingCreditFacilityMember2025-07-012025-12-310001696556ofrm:TrancheTwoMemberofrm:TermLoanFacilityMember2025-06-300001696556us-gaap:RetainedEarningsMember2026-01-012026-03-310001696556us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-310001696556us-gaap:EmployeeStockOptionMember2026-01-012026-09-300001696556us-gaap:MachineryAndEquipmentMember2026-09-300001696556us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2025-01-012025-09-3000016965562025-03-310001696556us-gaap:WarrantMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2026-02-2800016965562026-03-310001696556ofrm:ConvertiblePreferredStockWarrantLiabilityMember2026-09-300001696556ofrm:BabyProductMember2026-07-012026-09-300001696556us-gaap:RestrictedStockUnitsRSUMember2026-09-300001696556us-gaap:FairValueMeasurementsRecurringMember2025-12-310001696556us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2025-12-310001696556us-gaap:CommonStockMemberofrm:ConvertibleNotesMember2026-02-092026-02-090001696556us-gaap:AdditionalPaidInCapitalMember2025-03-310001696556us-gaap:RevolvingCreditFacilityMember2025-01-012025-09-3000016965562025-01-012025-09-300001696556us-gaap:EquityUnitPurchaseAgreementsMember2026-07-012026-09-300001696556ofrm:ConvertiblePreferredStockWarrantLiabilityMember2025-09-300001696556ofrm:ConvertiblePreferredStockWarrantLiabilityMember2026-02-280001696556us-gaap:CommonStockMember2026-04-012026-06-300001696556us-gaap:MeasurementInputExpectedDividendRateMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2025-12-310001696556us-gaap:CommonStockMember2025-01-012025-03-310001696556us-gaap:StockAppreciationRightsSARSMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2025-09-300001696556ofrm:KidSnacksMember2026-01-012026-09-3000016965562026-01-012026-03-310001696556us-gaap:RevolvingCreditFacilityMember2025-06-302025-06-300001696556ofrm:TermLoanFacilityMember2026-09-300001696556ofrm:KidPouchesMember2025-07-012025-09-300001696556us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2025-12-310001696556ofrm:KidSnacksMember2026-07-012026-09-300001696556us-gaap:AdditionalPaidInCapitalMember2024-12-310001696556us-gaap:CommonStockMemberofrm:ConvertiblePreferredStockWarrantsMember2026-02-090001696556us-gaap:NonUsMember2026-01-012026-09-300001696556us-gaap:ValuationTechniqueOptionPricingModelMemberofrm:ConvertiblePreferredStockWarrantLiabilityMemberus-gaap:MeasurementInputExpectedTermMember2025-12-310001696556us-gaap:WarrantMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2025-09-300001696556us-gaap:EmployeeStockOptionMember2025-12-310001696556us-gaap:ConvertibleNotesPayableMember2025-12-310001696556us-gaap:ConvertiblePreferredStockMember2026-01-012026-03-310001696556us-gaap:MeasurementInputRiskFreeInterestRateMemberus-gaap:ValuationTechniqueOptionPricingModelMemberofrm:ConvertiblePreferredStockWarrantLiabilityMember2025-12-310001696556us-gaap:WarrantMember2025-12-310001696556ofrm:ConvertiblePreferredStockWarrantsMember2025-12-310001696556us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberofrm:CustomerAMember2026-01-012026-09-300001696556us-gaap:RetainedEarningsMember2025-06-300001696556us-gaap:RestrictedStockUnitsRSUMember2026-07-012026-09-300001696556ofrm:BabyOtherMember2026-01-012026-09-300001696556us-gaap:EmployeeStockOptionMember2026-07-012026-09-300001696556us-gaap:MeasurementInputPriceVolatilityMemberus-gaap:ValuationTechniqueOptionPricingModelMemberofrm:ConvertiblePreferredStockWarrantLiabilityMember2025-12-310001696556us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2026-09-3000016965562026-02-012026-02-280001696556us-gaap:RetainedEarningsMember2025-03-310001696556ofrm:CustomerCMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-12-310001696556us-gaap:EquityUnitPurchaseAgreementsMember2025-01-012025-09-300001696556us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberofrm:CustomerAMember2025-01-012025-09-300001696556us-gaap:EquityUnitPurchaseAgreementsMember2026-01-012026-09-300001696556us-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:MeasurementInputDiscountRateMemberofrm:ConvertiblePreferredStockWarrantLiabilityMember2025-12-310001696556us-gaap:RevolvingCreditFacilityMember2026-01-012026-09-300001696556us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2024-12-3100016965562025-12-310001696556us-gaap:StockAppreciationRightsSARSMember2025-07-012025-09-300001696556us-gaap:CommonStockMember2026-01-012026-03-310001696556ofrm:CustomerBMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-09-300001696556us-gaap:CommonStockMember2024-12-310001696556us-gaap:StockAppreciationRightsSARSMember2026-02-052026-02-0500016965562026-01-220001696556us-gaap:RelatedPartyMemberofrm:SpokespersonAgreementMember2025-07-012025-09-300001696556us-gaap:SalesRevenueNetMemberofrm:CustomerCMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-09-300001696556us-gaap:RevolvingCreditFacilityMember2025-12-310001696556us-gaap:AdditionalPaidInCapitalMember2025-06-300001696556ofrm:SeriesDConvertibleNotesMember2025-12-310001696556ofrm:BabySnacksMember2025-07-012025-09-300001696556ofrm:SeriesA-2ConvertiblePreferredStockMember2025-12-310001696556us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberofrm:ConvertiblePreferredStockWarrantLiabilityMember2025-12-310001696556us-gaap:ConvertiblePreferredStockMemberofrm:TwoThousandAndTwentyTwoSeriesDOneWarrantMember2025-12-310001696556us-gaap:RelatedPartyMemberofrm:SpokespersonAgreementMember2026-02-280001696556us-gaap:ConstructionInProgressMember2026-09-300001696556us-gaap:CommonStockMemberofrm:SellingStockholdersMember2026-02-092026-02-090001696556us-gaap:SalesRevenueNetMemberofrm:CustomerBMemberus-gaap:CustomerConcentrationRiskMember2025-07-012025-09-300001696556ofrm:WalterRobbMember2026-09-300001696556us-gaap:CommonStockMemberus-gaap:IPOMember2026-02-012026-02-280001696556us-gaap:RetainedEarningsMember2024-12-310001696556us-gaap:WarrantMember2025-07-012025-09-3000016965562026-06-300001696556us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001696556us-gaap:RelatedPartyMemberofrm:SpokespersonAgreementMember2026-07-012026-09-3000016965562024-12-310001696556us-gaap:CommonStockMemberus-gaap:ConvertiblePreferredStockMember2026-02-092026-02-090001696556us-gaap:RetainedEarningsMember2026-09-300001696556ofrm:BabyPouchesMember2026-07-012026-09-300001696556us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2026-09-300001696556ofrm:TwoThousandTwentySixPlanMember2026-09-300001696556us-gaap:StockAppreciationRightsSARSMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2025-07-012025-09-300001696556ofrm:KidsProductMember2025-07-012025-09-300001696556us-gaap:CommonStockMember2025-06-300001696556us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2025-12-310001696556us-gaap:RetainedEarningsMember2026-06-300001696556us-gaap:MachineryAndEquipmentMember2025-12-3100016965562025-01-012025-03-310001696556ofrm:SeriesC-2ConvertibleNotesMember2025-12-310001696556us-gaap:FairValueMeasurementsRecurringMember2026-09-300001696556ofrm:BabyPouchesMember2026-01-012026-09-300001696556ofrm:TractorWheelsMemberus-gaap:SubsequentEventMember2026-10-312026-10-310001696556us-gaap:StockAppreciationRightsSARSMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2026-01-012026-09-300001696556ofrm:BabyOtherMember2026-07-012026-09-300001696556us-gaap:AdditionalPaidInCapitalMember2026-03-310001696556ofrm:BabySnacksMember2025-01-012025-09-3000016965562025-04-012025-06-300001696556ofrm:KidSnacksMember2025-01-012025-09-3000016965562026-01-230001696556ofrm:KidsProductMember2026-07-012026-09-3000016965562025-06-300001696556ofrm:HarbingerVenturesLLCMember2026-07-012026-09-300001696556us-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-300001696556ofrm:KidsProductMember2026-01-012026-09-3000016965562025-09-300001696556us-gaap:ConvertibleDebtSecuritiesMember2026-01-012026-09-300001696556us-gaap:CommonStockMember2025-07-012025-09-300001696556us-gaap:RelatedPartyMemberofrm:SpokespersonAgreementMember2026-05-012026-05-310001696556us-gaap:CommonStockMemberus-gaap:IPOMemberofrm:ConvertiblePreferredStockWarrantsMemberus-gaap:LineOfCreditMember2026-02-280001696556srt:MaximumMember2026-01-230001696556ofrm:BabyProductMember2026-01-012026-09-300001696556us-gaap:RetainedEarningsMember2026-04-012026-06-300001696556ofrm:BabyOtherMember2025-07-012025-09-300001696556us-gaap:SalesRevenueNetMemberofrm:CustomerCMemberus-gaap:CustomerConcentrationRiskMember2025-07-012025-09-300001696556us-gaap:AdditionalPaidInCapitalMember2026-04-012026-06-300001696556ofrm:KidPouchesMember2025-01-012025-09-300001696556us-gaap:CommonStockMember2026-07-012026-09-300001696556us-gaap:RelatedPartyMemberofrm:SpokespersonAgreementMember2025-01-012025-09-300001696556ofrm:TwoThousandTwentyOnePlanMember2025-12-310001696556us-gaap:SalesRevenueNetMemberofrm:CustomerBMemberus-gaap:CustomerConcentrationRiskMember2026-07-012026-09-300001696556ofrm:ConvertiblePreferredStockWarrantsMember2025-07-012025-09-300001696556us-gaap:StockAppreciationRightsSARSMember2025-01-012025-09-300001696556us-gaap:WarrantMember2026-07-012026-09-300001696556us-gaap:EmployeeStockOptionMemberofrm:TwoThousandAndTwentySixOmnibusPlanMember2026-02-050001696556us-gaap:RestrictedStockUnitsRSUMember2026-07-012026-09-300001696556us-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-300001696556us-gaap:EmployeeStockOptionMember2025-01-012025-09-300001696556us-gaap:RetainedEarningsMember2026-07-012026-09-300001696556us-gaap:EmployeeStockOptionMember2025-07-012025-09-300001696556us-gaap:RetainedEarningsMember2025-04-012025-06-300001696556us-gaap:NonrelatedPartyMembersrt:MinimumMember2026-01-012026-09-300001696556ofrm:BabyPouchesMember2025-01-012025-09-300001696556us-gaap:CommonStockMember2026-01-232026-01-230001696556us-gaap:StockAppreciationRightsSARSMemberus-gaap:SellingGeneralAndAdministrativeExpense2026-02-052026-02-050001696556ofrm:ConvertiblePreferredStockWarrantsMember2025-01-012025-09-300001696556us-gaap:RevolvingCreditFacilityMember2025-06-300001696556us-gaap:ConvertiblePreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2026-02-092026-02-090001696556us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberofrm:CustomerAMember2025-01-012025-12-310001696556us-gaap:CommonStockMember2025-04-012025-06-300001696556us-gaap:EmployeeStockOptionMember2025-01-012025-12-310001696556us-gaap:EmployeeStockOptionMembersrt:MaximumMember2026-01-012026-09-300001696556us-gaap:ConvertiblePreferredStockMember2025-09-300001696556us-gaap:EmployeeStockOptionMember2025-07-012025-09-300001696556us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-09-300001696556us-gaap:SalesRevenueNetMemberofrm:CustomerEMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-09-300001696556ofrm:BabyOtherMember2025-01-012025-09-300001696556us-gaap:ValuationTechniqueDiscountedCashFlowMemberofrm:ConvertiblePreferredStockWarrantLiabilityMemberus-gaap:MeasurementInputExpectedTermMember2025-12-310001696556us-gaap:CommonStockMember2026-06-300001696556ofrm:NonconvertibleDebtMember2026-01-012026-09-300001696556us-gaap:SalesRevenueNetMemberofrm:CustomerCMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-09-300001696556us-gaap:EquityUnitPurchaseAgreementsMember2025-07-012025-09-300001696556ofrm:ConvertiblePreferredStockWarrantLiabilityMember2025-12-310001696556us-gaap:AdditionalPaidInCapitalMember2025-09-300001696556us-gaap:CommonStockMemberus-gaap:OverAllotmentOptionMember2026-02-092026-02-0900016965562026-01-012026-09-300001696556ofrm:SeriesC-1ConvertiblePreferredStockMember2025-12-310001696556us-gaap:ConvertiblePreferredStockMemberofrm:TwoThousandAndTwentyOneSeriesBOneWarrantMember2025-12-310001696556ofrm:SeriesA-1ConvertiblePreferredStockMember2025-12-310001696556us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberofrm:CustomerAMember2025-07-012025-09-300001696556ofrm:SeriesB-1ConvertiblePreferredStockMember2025-12-310001696556ofrm:ConvertiblePreferredStockWarrantsMember2026-07-012026-09-300001696556us-gaap:StockAppreciationRightsSARSMemberofrm:TwoThousandTwentyOnePlanMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2025-01-012025-09-300001696556us-gaap:RelatedPartyMemberofrm:SpokespersonAgreementMember2026-05-310001696556us-gaap:WarrantMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2018-01-012024-12-310001696556us-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-300001696556ofrm:SeriesC-1ConvertibleNotesMember2025-12-3100016965562026-04-012026-06-300001696556us-gaap:RevolvingCreditFacilityMember2026-07-012026-09-300001696556ofrm:JohnForakerMember2026-09-300001696556ofrm:SeriesB-2ConvertiblePreferredStockMember2025-12-310001696556us-gaap:MeasurementInputRiskFreeInterestRateMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2025-12-310001696556ofrm:KidSnacksMember2025-07-012025-09-300001696556us-gaap:ConvertiblePreferredStockMember2026-02-100001696556us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2025-12-310001696556ofrm:TermLoanFacilityMember2025-06-300001696556us-gaap:EmployeeStockOptionMember2025-01-012025-09-300001696556us-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:MeasurementInputExpectedTermMember2025-12-310001696556ofrm:BabyProductMember2025-07-012025-09-300001696556us-gaap:SalesRevenueNetMemberofrm:CustomerBMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-09-300001696556us-gaap:NonrelatedPartyMembersrt:MinimumMember2025-01-012025-09-300001696556us-gaap:ConvertiblePreferredStockMember2025-06-300001696556us-gaap:CommonStockMemberus-gaap:IPOMember2026-02-092026-02-090001696556us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberofrm:CustomerAMember2026-07-012026-09-300001696556us-gaap:LeaseholdImprovementsMember2026-09-300001696556us-gaap:ConvertiblePreferredStockMember2024-12-310001696556ofrm:BabyProductMember2025-01-012025-09-300001696556ofrm:BabyPouchesMember2025-07-012025-09-300001696556ofrm:CustomerEMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-12-310001696556us-gaap:MeasurementInputPriceVolatilityMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2025-12-310001696556us-gaap:WarrantMember2026-01-012026-09-300001696556us-gaap:StockAppreciationRightsSARSMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2026-09-300001696556us-gaap:SalesRevenueNetMemberofrm:CustomerEMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-09-300001696556us-gaap:CommonStockMemberus-gaap:ConvertiblePreferredStockMemberus-gaap:IPOMember2026-02-012026-02-280001696556us-gaap:SalesRevenueNetMemberofrm:CustomerBMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-09-3000016965562026-02-102026-02-100001696556us-gaap:StockAppreciationRightsSARSMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2025-01-012025-09-300001696556us-gaap:StockAppreciationRightsSARSMember2025-03-272025-03-270001696556us-gaap:WarrantMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2026-09-300001696556us-gaap:StockAppreciationRightsSARSMember2026-01-012026-09-300001696556ofrm:ConvertiblePreferredStockWarrantLiabilityMember2024-12-310001696556us-gaap:RetainedEarningsMember2025-07-012025-09-300001696556us-gaap:SalesRevenueNetMemberofrm:CustomerEMemberus-gaap:CustomerConcentrationRiskMember2026-07-012026-09-300001696556ofrm:BabySnacksMember2026-07-012026-09-300001696556ofrm:WalterRobbMember2026-07-012026-09-300001696556us-gaap:ConvertiblePreferredStockMember2025-03-310001696556us-gaap:AdditionalPaidInCapitalMember2026-06-300001696556us-gaap:RestrictedStockUnitsRSUMember2026-02-052026-02-050001696556ofrm:BabySnacksMember2026-01-012026-09-300001696556us-gaap:RetainedEarningsMember2025-09-300001696556us-gaap:RelatedPartyMembersrt:MinimumMember2026-01-012026-09-300001696556ofrm:SeriesDConvertiblePreferredStockMember2025-12-310001696556us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberofrm:CustomerAMember2026-01-012026-09-300001696556us-gaap:MeasurementInputExpectedDividendRateMemberus-gaap:ValuationTechniqueOptionPricingModelMemberofrm:ConvertiblePreferredStockWarrantLiabilityMember2025-12-310001696556us-gaap:AdditionalPaidInCapitalMember2026-09-300001696556us-gaap:CommonStockMember2025-12-310001696556ofrm:TractorWheelsMember2026-01-012026-09-300001696556ofrm:KidPouchesMember2026-01-012026-09-300001696556us-gaap:RetainedEarningsMember2025-01-012025-03-310001696556us-gaap:EmployeeStockOptionMember2026-09-300001696556us-gaap:LeaseholdImprovementsMember2025-12-310001696556us-gaap:SalesRevenueNetMemberofrm:CustomerEMemberus-gaap:CustomerConcentrationRiskMember2025-07-012025-09-300001696556us-gaap:EmployeeStockOptionMembersrt:MinimumMember2026-01-012026-09-300001696556ofrm:ConvertiblePreferredStockWarrantLiabilityMember2026-01-012026-09-300001696556ofrm:TrancheOneMemberofrm:TermLoanFacilityMember2025-06-300001696556us-gaap:StockAppreciationRightsSARSMember2026-07-012026-09-300001696556ofrm:CustomerCMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-09-300001696556us-gaap:RelatedPartyMemberofrm:SpokespersonAgreementMember2025-01-310001696556ofrm:CassandraCurtisMember2026-07-012026-09-300001696556us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-09-300001696556ofrm:JohnForakerMember2026-07-012026-09-300001696556us-gaap:CommonStockMember2026-03-310001696556us-gaap:CommonStockMember2025-03-310001696556us-gaap:EmployeeStockOptionMember2026-07-012026-09-300001696556us-gaap:SalesRevenueNetMemberofrm:CustomerCMemberus-gaap:CustomerConcentrationRiskMember2026-07-012026-09-30xbrli:pureofrm:Unitxbrli:sharesofrm:Segmentiso4217:USDxbrli:sharesiso4217:USDutr:Y

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2026

OR

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-43108

 

Once Upon a Farm, PBC

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

47-3648280

( State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer
Identification No.)

950 Gilman Street, Suite 100

Berkeley, CA

94710

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (888) 983-1606

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.0001

 

OFRM

 

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

☐

Accelerated filer

☐

Non-accelerated filer

☒

Smaller reporting company

☐

 

 

 

 

Emerging growth company

 

☒

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of November 8, 2026, the registrant had 42,252,755 shares of common stock, $0.0001 par value per share, outstanding.

 

 


 

Table of Contents

 

 

 

Page

 

 

 

PART I.

FINANCIAL INFORMATION

 

 

 

Item 1.

Financial Statements (Unaudited)

1

 

Condensed Consolidated Balance Sheets

1

 

Condensed Consolidated Statements of Operations and Comprehensive Loss

2

 

Condensed Consolidated Statements of Convertible Preferred Stock And Stockholders’ Equity (Deficit)

3

 

Condensed Consolidated Statements of Cash Flows

5

 

Notes to Unaudited Condensed Consolidated Financial Statements

6

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

23

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

40

Item 4.

Controls and Procedures

41

 

 

 

PART II.

OTHER INFORMATION

42

 

 

 

Item 1.

Legal Proceedings

42

Item 1A.

Risk Factors

42

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

47

Item 3.

Defaults Upon Senior Securities

47

Item 4.

Mine Safety Disclosures

47

Item 5.

Other Information

47

Item 6.

Exhibits

48

Signatures

49

 

 

i


 

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements that reflect our expectations or beliefs regarding future events, including, but not limited to: statements about the markets in which we operate, including growth of our various markets, statements about potential new products and product innovation, and our expectations, beliefs, plans, strategies, objectives, prospects, assumptions, or future events or performance. These forward-looking statements, including expectations and projections about future matters, are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We caution that such statements involve numerous risks and uncertainties and are subject to variables that could impact our future performance. These statements are based on management’s views and assumptions at the time they are made and are not guarantees of future performance. Actual future events and performance may differ materially from the expectations reflected in our forward-looking statements. We do not undertake any obligation to update forward-looking statements.

A variety of factors could materially affect future outcomes, including, but not limited to: adverse public relations, product recalls, and product liability claims arising if our products are contaminated, alleged to be contaminated, or are rumored to have adverse effects, or if our products are alleged to cause illness or injury; factors outside of our and our suppliers’ control that disrupt our operations or impact the inputs, commodities, and ingredients that we use in our business; the failure to manage our supply chain effectively, including inventory levels and transportation and freight services; the availability of natural, plant-rich, and organic ingredients; the failure to increase our cooler count or lack of productivity in our cooler base; our ability to protect personal, proprietary, and confidential information and prevent security incidents; damage to the reputation of the Company, products, management team, or co-founders; adverse weather conditions, natural disasters, pestilence, climate change, and other conditions beyond our control that could disrupt our operations; the failure to retain and motivate our management team or other key team members, including our co-founders; our reliance on a limited number of independent contract manufacturers and suppliers, including co-packers; the loss of a significant customer; changing consumer preferences, perceptions, and spending habits; the failure to successfully pursue growth or implement our growth strategy on a timely basis or at all; changes in global and domestic economic and business conditions, and financial market conditions, such as continued inflation, interest rate increases, tariffs, trade wars, recession, government or regulator shutdowns or defunding, regulatory delays or uncertainty, supply chain disruptions or agricultural labor shortages; changes in global trade policy, including the imposition of tariffs on certain goods imported into the United States of America, uncertainty regarding the timing and amount of any tariff refund payments, or resultant trade wars that may lead to reduced economic activity, increased costs, reduced demand and changes in retail consumer purchasing behaviors for some or all of our products, or other potentially adverse economic outcomes; significant volatility in the cost or availability of inputs to our business (including freight, raw materials, packaging, energy, labor and other supplies), including as a result of tariffs or inflationary pressures; the impact of various worldwide or macroeconomic events, such as the ongoing conflicts in Europe, the Middle East and South America, and the continued effects of such conflict on U.S. and global economics, our employees, suppliers, customers and end consumers, which could adversely and materially impact our business, financial condition and results of operations; the inability to compete successfully in our highly competitive markets; any damage or disruption at any facility where our finished goods inventory is located; our ability to expand existing customer relationships and acquire new customers; the failure of our enterprise resource planning system or any deficient information-sharing capabilities; the sufficiency and effectiveness of our marketing and trade spending programs and whether we are able to develop and maintain our brand; the fluctuation in our business as a result of promotional activities and seasonality; our ability to implement initiatives to improve productivity and streamline operations to control or reduce costs; our ability to achieve or sustain profitability; our compliance and the compliance of our suppliers, co-packers, and co-manufacturers with applicable governmental laws and regulations; the ability of our information technology systems, including artificial intelligence technologies, to perform adequately and accurately; changes in tax laws; our status as a public benefit corporation and our duty to balance a variety of interests as a public benefit corporation; volatility of the market price of our common stock; the incurrence of increased costs as a result of operating as a public company; and the other factors set forth under Part II, Item 1A. “Risk Factors” of this Quarterly Report on Form 10-Q, Part I, Item 1A. “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and other filings that we make with the Securities and Exchange Commission (the “SEC”).

This list is not exhaustive and is intended for illustrative purposes only. Accordingly, all forward-looking statements should be evaluated with the understanding of their inherent uncertainty.

ii


 

Unless otherwise specified or unless the context requires otherwise, all references in this Quarterly Report on Form 10-Q to “Once Upon a Farm,” “the Company,” “we,” “us,” and “our,” or similar references, refer to Once Upon a Farm, PBC.

iii


 

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

ONCE UPON A FARM, PBC

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

(In thousands, except share amounts)

 

 

September 30,

 

 

December 31,

 

 

2026

 

 

2025

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

106,408

 

 

$

10,860

 

Accounts receivable, net

 

 

37,896

 

 

 

28,783

 

Inventory

 

 

45,591

 

 

 

46,981

 

Prepaid expenses and other current assets

 

 

4,266

 

 

 

15,520

 

Total current assets

 

 

194,161

 

 

 

102,144

 

Property and equipment, net

 

 

10,278

 

 

 

8,903

 

Intangible assets, net

 

 

502

 

 

 

561

 

Goodwill

 

 

4,244

 

 

 

4,244

 

Other non-current assets

 

 

862

 

 

 

567

 

Total assets

 

$

210,047

 

 

$

116,419

 

Liabilities, Convertible Preferred Stock and Stockholders’ Equity (Deficit)

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

14,661

 

 

$

19,606

 

Accrued expenses and other current liabilities

 

 

39,688

 

 

 

24,269

 

Total current liabilities

 

 

54,349

 

 

 

43,875

 

Nonconvertible debt, net

 

 

—

 

 

 

43,000

 

Convertible notes

 

 

—

 

 

 

17,214

 

Derivative liability

 

 

—

 

 

 

32,413

 

Other non-current liabilities

 

 

619

 

 

 

2,017

 

Total liabilities

 

 

54,968

 

 

 

138,519

 

Commitments and contingencies (Note 6)

 

 

 

 

 

 

Convertible preferred stock, $0.0001 par value; 100,000,000 and 1,347,305 shares authorized; no shares and 1,164,696 shares issued and outstanding as of September 30, 2026 and December 31, 2025; aggregate liquidation preference of $0 and $94,261 as of September 30, 2026 and December 31, 2025

 

 

—

 

 

 

101,967

 

Stockholders’ equity (deficit):

 

 

 

 

 

 

Common stock, $0.0001 par value; 1,000,000,000 and 38,250,607 shares
   authorized;
42,244,588 and 7,458,069 shares issued and outstanding
   as of September 30, 2026 and December 31, 2025

 

 

4

 

 

 

1

 

Additional paid-in capital

 

 

315,386

 

 

 

11,669

 

Accumulated deficit

 

 

(160,311

)

 

 

(135,737

)

Total stockholders’ equity (deficit)

 

 

155,079

 

 

 

(124,067

)

Total liabilities, convertible preferred stock and stockholders’ equity (deficit)

 

$

210,047

 

 

$

116,419

 

 

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.

1


 

ONCE UPON A FARM, PBC

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(UNAUDITED)

(In thousands, except share and per share amounts)

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Net sales

 

$

89,067

 

 

$

66,036

 

 

$

247,179

 

 

$

176,656

 

Cost of goods sold

 

 

56,915

 

 

 

38,251

 

 

 

154,700

 

 

 

105,325

 

Gross profit

 

 

32,152

 

 

 

27,785

 

 

 

92,479

 

 

 

71,331

 

Selling, general and administrative expenses

 

 

36,808

 

 

 

28,837

 

 

 

118,924

 

 

 

81,550

 

Loss from operations

 

 

(4,656

)

 

 

(1,052

)

 

 

(26,445

)

 

 

(10,219

)

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

(50

)

 

 

(801

)

 

 

(519

)

 

 

(1,984

)

Interest income

 

 

866

 

 

 

59

 

 

 

2,200

 

 

 

253

 

Change in fair value of derivative liability

 

 

—

 

 

 

(8,460

)

 

 

340

 

 

 

(26,320

)

Other income (expense), net

 

 

54

 

 

 

(462

)

 

 

(81

)

 

 

(1,447

)

Total other income (expense)

 

 

870

 

 

 

(9,664

)

 

 

1,940

 

 

 

(29,498

)

Net loss before income tax provision

 

 

(3,786

)

 

 

(10,716

)

 

 

(24,505

)

 

 

(39,717

)

Income tax provision

 

 

(27

)

 

 

(539

)

 

 

(69

)

 

 

(42

)

Net loss

 

$

(3,813

)

 

$

(11,255

)

 

$

(24,574

)

 

$

(39,759

)

Net loss per share attributable to common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(0.09

)

 

$

(1.66

)

 

$

(0.66

)

 

$

(5.95

)

Weighted-average shares used in computing net loss per share attributable to common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

 

42,107,010

 

 

 

6,786,312

 

 

 

37,033,622

 

 

 

6,678,886

 

 

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.

2


 

ONCE UPON A FARM, PBC

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)

(UNAUDITED)

(In thousands, except share amounts)

 

 

Convertible
Preferred Stock

 

 

 

Common Stock

 

 

Additional
Paid-In

 

 

Accumulated

 

 

Total
Stockholders’

 

 

Shares

 

 

Amount

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Equity (Deficit)

 

Balances at December 31, 2025

 

 

1,164,696

 

 

$

101,967

 

 

 

 

7,458,069

 

 

$

1

 

 

$

11,669

 

 

$

(135,737

)

 

$

(124,067

)

Issuance of common stock upon
   initial public offering, net of
   underwriting costs and offering
   costs of $
16,551

 

 

—

 

 

 

—

 

 

 

 

9,281,118

 

 

 

1

 

 

 

138,814

 

 

 

—

 

 

 

138,815

 

Conversion of convertible
   preferred stock into common
   stock

 

 

(1,164,696

)

 

 

(101,967

)

 

 

 

21,779,817

 

 

 

2

 

 

 

101,965

 

 

 

—

 

 

 

101,967

 

Conversion of convertible notes

 

 

—

 

 

 

—

 

 

 

 

2,819,512

 

 

 

—

 

 

 

18,678

 

 

 

—

 

 

 

18,678

 

Reclassification of derivative
   liability to equity

 

 

—

 

 

 

—

 

 

 

 

—

 

 

 

—

 

 

 

32,073

 

 

 

—

 

 

 

32,073

 

Issuance of common stock upon
   net exercise of warrants and
   reclassification of related
   warrant liability to equity

 

 

—

 

 

 

—

 

 

 

 

542,879

 

 

 

—

 

 

 

1,871

 

 

 

—

 

 

 

1,871

 

Exercise of stock options

 

 

 

 

 

 

 

 

 

8,997

 

 

 

 

 

 

17

 

 

 

 

 

 

17

 

Stock-based compensation

 

 

—

 

 

 

—

 

 

 

 

—

 

 

 

—

 

 

 

4,338

 

 

 

—

 

 

 

4,338

 

Net loss

 

 

—

 

 

 

—

 

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(15,811

)

 

 

(15,811

)

Balances at March 31, 2026

 

 

—

 

 

$

—

 

 

 

 

41,890,392

 

 

$

4

 

 

$

309,425

 

 

$

(151,548

)

 

$

157,881

 

Additional offering costs related to the initial public offering

 

 

—

 

 

 

—

 

 

 

 

—

 

 

 

—

 

 

 

(349

)

 

 

—

 

 

 

(349

)

Exercise of stock options

 

 

—

 

 

 

—

 

 

 

 

89,419

 

 

 

—

 

 

 

229

 

 

 

—

 

 

 

229

 

Stock-based compensation

 

 

—

 

 

 

—

 

 

 

 

—

 

 

 

—

 

 

 

2,471

 

 

 

—

 

 

 

2,471

 

Net loss

 

 

—

 

 

 

—

 

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(4,950

)

 

 

(4,950

)

Balances at June 30, 2026

 

 

—

 

 

$

—

 

 

 

 

41,979,811

 

 

$

4

 

 

$

311,776

 

 

$

(156,498

)

 

$

155,282

 

Vesting of restricted stock units

 

 

—

 

 

 

—

 

 

 

 

117,789

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

Exercise of stock options

 

 

—

 

 

 

—

 

 

 

 

146,988

 

 

 

—

 

 

 

615

 

 

 

—

 

 

 

615

 

Stock-based compensation

 

 

—

 

 

 

—

 

 

 

 

—

 

 

 

—

 

 

 

2,995

 

 

 

—

 

 

 

2,995

 

Net loss

 

 

—

 

 

 

—

 

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(3,813

)

 

 

(3,813

)

Balances at September 30, 2026

 

 

—

 

 

$

—

 

 

 

 

42,244,588

 

 

$

4

 

 

$

315,386

 

 

$

(160,311

)

 

$

155,079

 

 

3


 

ONCE UPON A FARM, PBC

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)

(UNAUDITED) - CONTINUED

 

(In thousands, except share amounts)

 

 

Convertible
Preferred Stock

 

 

 

Common Stock

 

 

Additional
Paid-In

 

 

Accumulated

 

 

Total
Stockholders’

 

 

Shares

 

 

Amount

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances at December 31, 2024

 

 

1,164,696

 

 

$

101,967

 

 

 

 

6,575,609

 

 

$

1

 

 

$

6,349

 

 

$

(118,488

)

 

$

(112,138

)

Exercise of stock options

 

 

—

 

 

 

—

 

 

 

 

59,748

 

 

 

—

 

 

 

127

 

 

 

—

 

 

 

127

 

Stock-based compensation

 

 

—

 

 

 

—

 

 

 

 

—

 

 

 

—

 

 

 

805

 

 

 

—

 

 

 

805

 

Net loss

 

 

—

 

 

 

—

 

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(19,466

)

 

 

(19,466

)

Balances at March 31, 2025

 

 

1,164,696

 

 

$

101,967

 

 

 

 

6,635,357

 

 

$

1

 

 

$

7,281

 

 

$

(137,954

)

 

$

(130,672

)

Exercise of stock options

 

 

—

 

 

 

—

 

 

 

 

47,129

 

 

 

—

 

 

 

104

 

 

 

—

 

 

 

104

 

Stock-based compensation

 

 

—

 

 

 

—

 

 

 

 

—

 

 

 

—

 

 

 

1,093

 

 

 

—

 

 

 

1,093

 

Net loss

 

 

—

 

 

 

—

 

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(9,038

)

 

 

(9,038

)

Balances at June 30, 2025

 

 

1,164,696

 

 

$

101,967

 

 

 

 

6,682,486

 

 

$

1

 

 

$

8,478

 

 

$

(146,992

)

 

$

(138,513

)

Exercise of stock options

 

 

—

 

 

 

—

 

 

 

 

775,583

 

 

 

—

 

 

 

1,174

 

 

 

—

 

 

 

1,174

 

Stock-based compensation

 

 

—

 

 

 

—

 

 

 

 

—

 

 

 

—

 

 

 

997

 

 

 

—

 

 

 

997

 

Net loss

 

 

—

 

 

 

—

 

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(11,255

)

 

 

(11,255

)

Balances at September 30, 2025

 

 

1,164,696

 

 

$

101,967

 

 

 

 

7,458,069

 

 

$

1

 

 

$

10,649

 

 

$

(158,247

)

 

$

(147,597

)

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.

4


 

ONCE UPON A FARM, PBC

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

(In thousands)

 

 

Nine Months Ended September 30,

 

 

2026

 

 

2025

 

OPERATING ACTIVITIES

 

 

 

 

 

 

Net loss

 

$

(24,574

)

 

$

(39,759

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

Change in fair value of derivative liability

 

 

(340

)

 

 

26,320

 

Change in fair value of convertible preferred stock warrant liability

 

 

(13

)

 

 

1,365

 

Change in fair value of SARs liability

 

 

(2

)

 

 

39

 

Stock-based compensation

 

 

9,804

 

 

 

2,895

 

SARs issued to a customer recorded as a reduction to revenue

 

 

183

 

 

 

63

 

Inventory adjustments

 

 

4,361

 

 

 

1,761

 

Depreciation and amortization

 

 

1,657

 

 

 

907

 

Amortization of debt discounts and deferred financing costs

 

 

148

 

 

 

451

 

Non-cash interest

 

 

29

 

 

 

221

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

(9,113

)

 

 

(12,120

)

Inventory

 

 

(2,971

)

 

 

(19,588

)

Prepaid expenses and other assets

 

 

(2,615

)

 

 

(439

)

Accounts payable

 

 

(2,001

)

 

 

4,841

 

Accrued expenses and other liabilities

 

 

20,847

 

 

 

9,807

 

Net cash used in operating activities

 

 

(4,600

)

 

 

(23,236

)

INVESTING ACTIVITIES

 

 

 

 

 

 

Purchase of property and equipment

 

 

(3,438

)

 

 

(3,539

)

Net cash used in investing activities

 

 

(3,438

)

 

 

(3,539

)

FINANCING ACTIVITIES

 

 

 

 

 

 

Proceeds from issuance of common stock

 

 

155,366

 

 

 

—

 

Proceeds from term loan facility

 

 

—

 

 

 

14,000

 

Proceeds from line of credit

 

 

—

 

 

 

7,000

 

Proceeds from exercise of stock options

 

 

861

 

 

 

1,405

 

Payment of debt issuance costs

 

 

—

 

 

 

(463

)

Repayment of line of credit

 

 

(43,000

)

 

 

—

 

Payment of offering costs

 

 

(9,641

)

 

 

—

 

Payment of deferred offering costs

 

 

—

 

 

 

(5,061

)

Net cash provided by financing activities

 

 

103,586

 

 

 

16,881

 

Net change in cash and cash equivalents

 

 

95,548

 

 

 

(9,894

)

Cash and cash equivalents, beginning of period

 

 

10,860

 

 

 

17,306

 

Cash and cash equivalents, end of period

 

$

106,408

 

 

$

7,412

 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION

 

 

 

 

 

 

Cash paid for interest

 

$

342

 

 

$

1,311

 

Cash paid for income taxes

 

$

—

 

 

$

3

 

SUPPLEMENTAL DISCLOSURE OF NON-CASH
   INVESTING AND FINANCING ACTIVITIES

 

 

 

 

 

 

Reallocation of borrowings from term loan to line of credit

 

$

—

 

 

$

22,000

 

Capital expenditures included in accounts payable and accrued expenses

 

$

173

 

 

$

473

 

Deferred offering costs included in accounts payable and accrued expenses

 

$

—

 

 

$

3,831

 

Deferred offering costs transferred to additional paid in capital

 

$

13,987

 

 

$

—

 

Conversion of convertible preferred stock to common stock

 

$

101,967

 

 

$

—

 

Conversion of convertible notes to equity

 

$

18,678

 

 

$

—

 

Reclassification of derivative liability to equity

 

$

32,073

 

 

$

—

 

Reclassification of convertible warrant liability to equity

 

$

1,871

 

 

$

—

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.

5


 

ONCE UPON A FARM, PBC

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1.
nature of business

Once Upon a Farm, PBC (the “Company”) is a Delaware public benefit corporation, which began operations in 2014. The Company is engaged in the manufacturing; distribution; marketing and related sale of innovative, nutrient-packed, delicious food for babies and kids of on-the-go parents (under the brand name, Once Upon a Farm). The Company's products include Pouches and snacks. Sales of the Company’s products are made primarily throughout the United States. The Company's headquarters is in Berkeley, California.

Initial Public Offering

On February 9, 2026, the Company completed its initial public offering (the “IPO”) of 7,631,537 shares of its common stock at the public offering price of $18.00 per share, plus an additional 1,649,581 shares of common stock at the same public offering price pursuant to the exercise of the underwriters' option to purchase additional shares. The Company received approximately $138.5 million in aggregate proceeds, net of underwriting discounts and commissions and offering costs. In connection with the IPO, certain of the Company's stockholders (the “Selling Stockholders”) sold 3,365,672 shares of common stock. The Company did not receive any of the proceeds from the sale of shares by the Selling Stockholders.

Immediately prior to the closing of the IPO, all outstanding convertible notes (“Convertible Notes”) (See Note 8, Convertible Notes) were converted into their respective classes of convertible preferred stock, which then immediately converted into 2,819,512 shares of common stock (see Note 8, Convertible Notes). Further, all outstanding shares of the Company’s convertible preferred stock were converted into 21,779,817 shares of the Company’s common stock at the applicable conversion ratio then in effect (see Note 9, Convertible Preferred Stock) and the related carrying value of $102.0 million was reclassified from temporary equity to additional paid in capital. Subsequent to the closing of the IPO, there were no shares of convertible preferred stock outstanding. The carrying values of the notes, together with accrued interest, and related derivative liability, which was remeasured to fair value on the IPO date, were reclassified to additional paid-in capital. Additionally, upon the consummation of the IPO, all of the then-outstanding convertible preferred stock warrants issued to a customer were automatically net exercised into 438,983 shares of common stock (see Note 11, Stock-based Compensation) and the convertible preferred stock warrants issued in connection with a credit facility were net exercised into 103,896 shares of common stock (see Note 7, Nonconvertible Debt and Warrants).

Forward Stock Split and Change in Par Value

On January 23, 2026, the Company effected an 18.7-for-1 forward stock split (the “Forward Stock Split”) of its issued and outstanding shares of common stock, as well as stock options to purchase shares of common stock, restricted stock awards and stock appreciation rights. In connection with the Forward Stock Split, the Company changed the par value of its capital stock from $0.001 to $0.0001 and amended its certificate of incorporation to authorize the issuance of up to 1,000,000,000 shares of common stock, $0.0001 par value per share, and 100,000,000 shares of preferred stock, $0.0001 par value per share. Accordingly, all share and per share amounts related to common stock for all periods presented in the accompanying condensed financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect the effect of the Forward Stock Split. As the number of all outstanding convertible preferred stock remained unchanged, the conversion ratios for each series of the Company’s convertible preferred stock were retroactively adjusted as a result of the Forward Stock Split.

6


 

2.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

The significant accounting policies and estimates used in the preparation of the unaudited condensed consolidated financial statements are described in the Company’s audited consolidated financial statements as of and for the year ended December 31, 2025, and the notes thereto, which are included in the Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 16, 2026. During the nine months ended September 30, 2026, there were no significant changes to the Company’s significant accounting policies as described in the Company’s audited financial statement as of and for the year ended December 31, 2025.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). The condensed consolidated financial statements include all the accounts of the Company's wholly-owned subsidiary. All intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of these condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but are not limited to, net realizable value of inventory; revenue recognition, including variable consideration for sales promotions and discounts; the valuation of stock-based awards, including the valuation of common stock; useful lives and valuation of long-lived assets; intangible assets and goodwill; valuation of derivative liability; valuation of preferred stock warrant liabilities; and provision for income taxes, including related reserves. Management periodically evaluates its estimates, which are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from those estimates.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of demand deposit accounts, money market accounts and accounts receivable. The Company maintains its cash and cash equivalents, which may, at times, exceed federally insured limits, with financial institutions of high credit standing. As of September 30, 2026, the Company has not experienced any losses on its deposit accounts and money market accounts. As of September 30, 2026, the Company does not believe there is significant financial risk from nonperformance by the issuers of the Company’s deposit accounts and money market accounts.

Customers with 10% or more of the Company’s net sales or accounts receivable consist of the following for the periods indicated:

 

 

Accounts Receivable

 

Net Sales

 

September 30,

 

December 31,

 

For the Three Months Ended September 30,

 

For the Nine Months Ended September 30,

 

2026

 

2025

 

2026

 

2025

 

2026

 

2025

Customer A

 

30%

 

31%

 

20%

 

25%

 

19%

 

24%

Customer B

 

14%

 

**

 

14%

 

16%

 

13%

 

12%

Customer C

 

15%

 

14%

 

11%

 

13%

 

13%

 

13%

Customer D

 

10%

 

12%

 

**

 

**

 

**

 

**

Customer E

 

**

 

11%

 

21%

 

12%

 

19%

 

14%

 

** Represents less than 10% of accounts receivable or net sales as applicable

7


 

Deferred Offering Costs

The Company capitalized certain legal, professional accounting and other third-party fees that are directly associated with its IPO as deferred offering costs until such offering is consummated. As of December 31, 2025, there was $14.0 million of deferred offering costs capitalized and included in prepaid expenses and other current assets in the condensed consolidated balance sheets. Upon closing of the IPO in February 2026, $16.9 million of offering costs, including $14.0 million of deferred offering costs capitalized as of December 31, 2025, were offset against the IPO proceeds and reclassified to additional paid-in capital.

Vendor Rebates

On February 20, 2026, the U.S. Supreme Court invalidated reciprocal tariffs collected under the International Emergency Economic Powers Act. Following subsequent Court of International Trade enforcement orders, the Company’s vendors, who passed along tariffs costs to the Company, may claim refunds through U.S. Customs and Border Protection's Consolidated Administration and Processing of Entries portal. Some of the Company’s vendors must contractually reimburse the Company a portion of passed-through tariff costs upon receiving their refund, while others have no such contractual obligation. For the latter, the Company is negotiating to receive a portion of the refunds.

The Company accounts for these tariff reimbursements as vendor rebates. Contractually required rebates are recognized as a reduction of product purchase prices (and thus costs of goods sold) when the receipt from the vendor becomes probable. For rebates received that are not required to be paid under a pre-existing contractual arrangements, when it becomes probable that the rebate will be received, the rebate will be deferred and recognized as a reduction of future purchase prices. As of September 30, 2026, the tariff reimbursements received or recognized to date by the Company have not been material.

Recently Adopted Accounting Pronouncements

In July 2025, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2025-05, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets (“ASU 2025-05”). ASU 2025-05 provides a practical expedient that all entities can use when estimating expected credit losses for current accounts receivable and current contract assets arising from transactions accounted for under ASC 606, Revenue from Contracts with Customers. Under this practical expedient, an entity is allowed to assume that the current conditions it has applied in determining credit loss allowances for current accounts receivable and current contract assets remain unchanged for the remaining life of those assets. ASU 2025-05 is effective for fiscal years beginning after December 15, 2025, and interim reporting periods in those years. Entities that elect the practical expedient and, if applicable, make the accounting policy election are required to apply the amendments prospectively. The Company adopted ASU 2025-05 effective for the annual period beginning January 1, 2026 and it did not have a material impact on the accompanying condensed consolidated financial statements and disclosures.

Recent Accounting Pronouncements Not Yet Adopted

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 enhances the transparency and decision usefulness of income tax disclosures. Adjustments to the annual disclosure of income taxes include: (1) a tabular rate reconciliation comprised of eight specific categories, (2) incomes taxes paid, disaggregated between significant national, state, and foreign jurisdictions, (3) eliminates requirements to disclose the nature and estimate of reasonably possible changes to unrecognized tax benefits in the next 12 months or that an estimated range cannot be made, and (4) adds a requirement to disclose income (or loss) from continuing operations before income tax expense (or benefit) by national and foreign; and income tax expense (or benefit) from continuing operations disaggregated between national, state and foreign. The ASU is effective for public business entities for fiscal years beginning on or after December 15, 2024, and for all other entities for fiscal years beginning on or after December 31, 2025, with early adoption permitted. Due to the Company's Emerging Growth Company status, the Company may elect not to adopt new or revised accounting standards until they become effective for private companies. Accordingly, the Company will

8


 

adopt ASU 2023-09 for its annual financial statements for the year ending December 31, 2026. The Company is currently evaluating the requirements of the new standard and the effect on its condensed consolidated financial statements and the related disclosures.

In November 2024, the FASB issued ASU No. 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”). ASU 2024-03 requires additional disclosure of the nature of expenses included in the income statement as well as disclosures about specific types of expenses included in the expense captions within the income statement. In January 2025, the FASB issued ASU No. 2025-01, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40) Clarifying the Effective Date. The amendments in this update may be applied either prospectively or retrospectively, and are effective for fiscal years beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027. The Company is evaluating the impact that this guidance will have on its condensed consolidated financial statements and related disclosures.

In September 2025, the FASB issued ASU No. 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software (“ASU 2025-06”). ASU 2025-06 removes the existing project stage model and introduces new capitalization criteria based on management authorization and the probability of project completion. It also clarifies the treatment of software development uncertainty and incorporates guidance on website development costs. ASU 2025-06 is effective for the Company for annual reporting periods beginning after December 15, 2027, and interim periods within those annual periods, with early adoption permitted. ASU 2025-06 may be applied prospectively, retrospectively, or through a modified transition approach. The Company is evaluating the impact that this guidance will have on its condensed consolidated financial statements and related disclosures, including its expected transition method.

In September 2025, the FASB issued ASU No. 2025-07, Derivatives and Hedging (Topic 815) and Revenue from Contracts with Customers (Topic 606): Derivatives Scope Refinements and Scope Clarification for Share-Based Noncash Consideration From a Customer in a Revenue Contract (“ASU 2025-07”). ASU 2025-07 introduces guidance for applying derivative accounting to contracts that include features tied to the operations or activities of one of the parties to the contract. It also aims to reduce diversity in how share-based payments are accounted for in revenue contracts. ASU 2025-07 will be effective for the annual periods beginning after December 15, 2026 with early adoption permitted. The Company is evaluating the impact that this guidance will have on its condensed consolidated financial statements and related disclosures.

3.
Fair value measurements

The Company had no financial assets or liabilities measured at fair value on a recurring basis at September 30, 2026.

The following table presents the Company’s financial liabilities measured at fair value on a recurring basis for the period indicated (in thousands):

 

December 31, 2025

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Derivative liability

 

$

—

 

 

$

—

 

 

$

32,413

 

 

$

32,413

 

Convertible preferred stock warrant liability

 

 

—

 

 

 

—

 

 

 

1,884

 

 

 

1,884

 

 

$

—

 

 

$

—

 

 

$

34,297

 

 

$

34,297

 

Derivative Liability

The Convertible Notes contained a conversion feature that met the definition of an embedded derivative that required bifurcation and measurement at fair value (Note 8, Convertible Notes). The Company estimated the fair value of the embedded derivative using a “with-and-without” model. The “with-and-without”

9


 

methodology involves valuing the whole instrument on an as-is basis and then valuing the instrument without the individual embedded derivative. The difference between the entire instrument with the embedded derivative compared to the instrument without the embedded derivative was the fair value of the derivative liability on issuance. The estimated probability and timing of underlying events triggering the conversion features contained within the Convertible Notes are inputs used to determine the estimated fair value of the entire instrument with the embedded derivative. The fair values are subjective and are affected by certain significant inputs. Changes in the estimated fair value were recognized in the Company's statements of operations and comprehensive loss. Upon conversion of the Convertible Notes in connection with Company’s IPO in February 2026, the derivative liability was remeasured to fair value, and the carrying values of the Convertible Notes and the derivative liability were reclassified to additional paid-in capital.

The Company used the following assumptions to determine the fair value of the derivative liability for the period indicated:

 

 

December 31,

 

2025

Risk-free interest rate

 

3.58%

Expected term (in years)

 

0.10

Volatility

 

62.90%

Dividend yield

 

—%

 

The following table provides a summary of the change in the estimated fair value of the Company’s derivative liability (in thousands):

 

Fair value as of December 31, 2025

 

$

32,413

 

Change in fair value

 

 

(340

)

Reclassification to additional paid-in capital upon conversion

 

 

(32,073

)

Fair value as of September 30, 2026

 

$

—

 

 

Fair value as of December 31, 2024

 

$

23,847

 

Change in fair value

 

 

26,320

 

Fair value as of September 30, 2025

 

$

50,167

 

 

Convertible Preferred Stock Warrant Liability

The Company estimated the fair values of its convertible preferred stock warrant liability using a hybrid valuation approach. The hybrid approach assigns a probability weighting to both a merger and acquisition (“M&A”) scenario and an initial public offering scenario. For the M&A scenario, the Company utilized the Income Approach and Guideline Public Company (“GPC”) to determine the estimated fair value of equity, which was then allocated to the various classes of equity using approach and the Option Pricing Method (“OPM”). Under the OPM, the shares are valued by creating a series of call options with exercise prices based on the liquidation preferences and conversion terms of each equity class. The estimated fair values of the common stock, preferred stock and preferred stock warrants are then inferred by analyzing these options. The OPM assumptions are based on the individual characteristics of the warrants on the valuation date, and assumptions related to fair value of the underlying stock, risk-free rate, expected volatility, dividends and an expected term based on the estimated time to a liquidity event.

For the initial public offering scenario, the Company estimated the exit value upon an IPO and then performed a waterfall analysis to systemically allocate the equity value across share classes accordingly to their fully diluted ownership percentages. This method estimates the future value of each share class under the initial public offering scenario, adjusts for option and warrant proceeds and discounts the resulting value to present terms using an appropriate discount rate.

10


 

In determining the fair value of the convertible preferred stock warrant liability, the following assumptions were used:

 

 

 

December 31,

 

 

2025

 

 

OPM

 

Waterfall

Risk-free interest rate

 

3.58%

 

N/A

Discount Rate

 

N/A

 

12.50%

Expected term (in years)

 

0.50

 

0.08

Volatility

 

62.90%

 

N/A

Dividend yield

 

—%

 

N/A

 

The following table provides a summary of the change in the estimated fair value of the Company’s convertible preferred stock warrant liability (in thousands):

 

Fair value as of December 31, 2025

 

$

1,884

 

Change in fair value

 

 

(13

)

Reclassification to additional paid-in capital upon net exercise

 

 

(1,871

)

Fair value as of September 30, 2026

 

$

—

 

 

Fair value as of December 31, 2024

 

$

1,396

 

Change in fair value

 

 

1,365

 

Fair value as of September 30, 2025

 

$

2,761

 

 

In February 2026, following the consummation of the IPO, all then-outstanding convertible preferred stock warrants issued in connection with a credit facility were net exercised, resulting in the issuance of 103,896 shares of common stock, and the related warrant liability was remeasured to fair value as of the IPO date and reclassified to stockholders’ equity (deficit) (see Note 7, Nonconvertible Debt and Warrants).

4.
REVENUE RECOGNITION

The following table presents disaggregated net sales by product category (in thousands):

 

 

Three Months Ended September 30,

 

 

 

Nine Months Ended September 30,

 

 

2026

 

 

2025

 

 

 

2026

 

 

 

2025

 

Kid

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pouches

 

$

37,473

 

 

$

29,956

 

 

$

 

103,121

 

 

$

 

88,159

 

Snacks

 

 

4,767

 

 

 

6,163

 

 

 

 

17,179

 

 

 

 

16,433

 

Total Kid

 

 

42,240

 

 

 

36,119

 

 

 

 

120,300

 

 

 

 

104,592

 

Baby

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pouches

 

 

11,608

 

 

 

9,634

 

 

 

 

34,371

 

 

 

 

21,595

 

Snacks

 

 

34,818

 

 

 

19,766

 

 

 

 

91,229

 

 

 

 

48,650

 

Other

 

 

401

 

 

 

517

 

 

 

 

1,279

 

 

 

 

1,819

 

Total Baby

 

 

46,827

 

 

 

29,917

 

 

 

 

126,879

 

 

 

 

72,064

 

Total net sales

 

$

89,067

 

 

$

66,036

 

 

$

 

247,179

 

 

$

 

176,656

 

 

11


 

5.
Balance Sheet Components

Inventory

Inventory consists of the following (in thousands):

 

 

September 30,

 

 

December 31,

 

 

2026

 

 

2025

 

Raw materials

 

$

23,212

 

 

$

21,539

 

Finished goods

 

 

22,379

 

 

 

25,442

 

Total inventory

 

$

45,591

 

 

$

46,981

 

 

Property and Equipment, net

Property and equipment, net consists of the following (in thousands):

 

 

September 30,

 

 

December 31,

 

 

2026

 

 

2025

 

Machinery and equipment

 

$

13,559

 

 

$

7,948

 

Leasehold improvements

 

 

78

 

 

 

78

 

Purchased software

 

 

555

 

 

 

555

 

Construction in progress

 

 

342

 

 

 

2,980

 

Total property and equipment

 

 

14,534

 

 

 

11,561

 

Accumulated depreciation and amortization

 

 

(4,256

)

 

 

(2,658

)

Total property and equipment, net

 

$

10,278

 

 

$

8,903

 

 

Depreciation and amortization of property and equipment was $0.6 million and $0.3 million for the three months ended September 30, 2026 and 2025, and $1.6 million and $0.8 million for the nine months ended September 30, 2026 and 2025.

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consists of the following (in thousands):

 

 

September 30,

 

 

December 31,

 

 

2026

 

 

2025

 

Accrued promotional activities

 

$

12,999

 

 

$

6,015

 

Accrued inventory purchases

 

 

9,884

 

 

 

1,939

 

Accrued marketing

 

 

4,278

 

 

 

2,320

 

Accrued payroll expenses

 

 

3,654

 

 

 

2,811

 

Accrued third-party manufacturing fees

 

 

3,129

 

 

 

565

 

Accrued deferred offering costs

 

 

—

 

 

 

3,783

 

Accrued interest

 

 

—

 

 

 

1,435

 

Accrued other expenses

 

 

5,575

 

 

 

5,351

 

Operating lease liabilities, current portion

 

 

169

 

 

 

50

 

Total accrued expenses and other current liabilities

 

$

39,688

 

 

$

24,269

 

 

12


 

6.
Commitments and Contingencies

Purchase Commitments

The Company has a minimum purchase commitment with an outsourced manufacturer of its snack bars of 10,000,000 units per year, or 50,000,000 units over five years. Based on the current pricing, the remaining future minimum purchase commitment under the non-cancellable purchase agreement as of September 30, 2026 is as follows (in thousands):

 

Year Ending December 31,

 

Amount

 

2026 (remainder)

 

$

270

 

2027

 

 

1,900

 

2028

 

 

1,900

 

2029

 

 

1,900

 

Total

 

$

5,970

 

Litigation

The Company may become involved in legal proceedings from time to time. The Company does not believe that any legal proceeding or claims currently pending against it, individually or in the aggregate, are material, or will have a material adverse effect on its financial condition, results of operations or cash flows.

7.
NONCONVERTIBLE Debt AND WARRANTS

Nonconvertible Debt

In June 2025, the Company and the lender entered into an agreement to replace an existing term loan and revolving credit facility (together the “Existing Credit Agreement”) for a delayed draw term loan (the “Term Loan Facility”) and a revolving credit facility (the “Revolving Credit Facility” and together with the Term Loan Facility, the “Nonconvertible Debt”). The Revolving Credit Facility has a maximum capacity of $65.0 million. The maximum amount available under the Revolving Credit Facility is calculated as the lower of (a) the current maximum capacity and (b) the sum of (i) 80% of the Company’s gross accounts receivable and (ii) 85% of the liquidation value of inventory, each subject to certain adjustments. The Term Loan Facility has a maximum capacity of $30.0 million. The Term Loan Facility is available in two tranches: (i) an $18.0 million tranche that is available immediately and (ii) a $12.0 million tranche that is contingent on the Company achieving certain funding milestones prior to March 31, 2026 (which were achieved upon the completion of the IPO).

Upon closing of the Nonconvertible Debt in June 2025, the Company drew $22.0 million under the Revolving Credit Facility in order to repay the outstanding balances on the Existing Credit Agreement. During the second half of 2025, the Company drew an additional $21.0 million under the Revolving Credit Facility for general corporate purposes. There were no lender fees or third-party expenses incurred related to these draws. As of December 31, 2025, $43.0 million was outstanding under the Revolving Credit Facility and the interest rate applicable to borrowings under the Revolving Credit Facility was 7.0%.

Following completion of the IPO, the Company used a portion of the proceeds to repay all outstanding amounts under the Nonconvertible Debt. Accordingly, the Company repaid $43.0 million on February 10, 2026. As of September 30, 2026, the Company had no outstanding borrowings under the Term Loan Facility or the Revolving Credit Facility and the Company had up to $30.0 million available to draw under the Term Loan Facility and $65.0 million to draw under its Revolving Credit Facility, of which $58.2 million available for borrowing based on existing inventory and accounts receivable balances as described by Revolving Credit Facility, .

For the three months ended September 30, 2026 and 2025, interest expense for the Nonconvertible Debt was $0.1 million and $0.6 million, including amortization of debt issuance costs and discounts, which was $0.1 million and an immaterial amount. For the nine months ended September 30, 2026 and 2025, interest expense

13


 

for the Nonconvertible Debt was $0.5 million and $1.4 million, including amortization of debt issuance costs and discounts, which was $0.1 million in each period. As of September 30, 2026 and December 31, 2025, the Company had $0.3 million and $0.4 million of unamortized debt issuance costs within other assets on the balance sheet related to the Nonconvertible Debt.

The Company is subject to certain financial and nonfinancial covenants under the provisions of the Nonconvertible Debt, including maintaining a minimum cash balance with the lender of $4.0 million, restrictions on paying any dividends to its common and preferred shareholders, limits on the types of other debt financing that can be obtained and limits on certain capital expenditures, among other things. As of September 30, 2026 and December 31, 2025, the Company was in compliance with all covenants.

Nonconvertible Debt Warrants

In connection with the initial issuance and various amendments to the Existing Credit Agreement, the Company issued to the lender warrants to purchase shares of the Company's Series B-1 convertible preferred stock and Series D convertible preferred stock (the “Convertible Preferred Stock Warrants”).

The total outstanding Convertible Preferred Stock Warrants as of December 31, 2025 are summarized as follows:

 

 

 

Issuance Date

 

Warrants
Outstanding

 

 

Exercise Price

 

 

Expiration
Date

2020 Series B-1 Warrant

 

February 2020

 

 

2,830

 

 

$

58.38

 

 

September 2032

2021 Series B-1 Warrant

 

May 2021

 

 

2,830

 

 

$

58.38

 

 

September 2032

2022 Series D Warrant

 

September 2022

 

 

963

 

 

$

183.03

 

 

September 2032

2022 Series D Warrant

 

September 2023

 

 

963

 

 

$

183.03

 

 

September 2032

Total

 

 

 

 

7,586

 

 

 

 

 

 

 

The above table excludes convertible preferred stock warrants issued to a customer (see Note 11, Stock-based Compensation).

The Convertible Preferred Stock Warrants were accounted for as a derivative liability and classified in other non-current liabilities on the balance sheets because the underlying convertible preferred stock was contingently redeemable outside of the Company's control. The aggregate estimated fair value was $1.9 million as of December 31, 2025.

In February 2026, upon the consummation of the IPO, all then-outstanding Convertible Preferred Stock Warrants issued in connection with a credit facility were net exercised, resulting in the issuance of 103,896 shares of common stock. As a result of the net exercise of the Convertible Preferred Stock warrants associated with the credit facility, the warrant liability was remeasured to fair value at the IPO date and was reclassified to stockholders’ equity (deficit).

14


 

8.
CONVERTIBLE NOTES

The tables below summarize the Company’s outstanding Convertible Notes for the period indicated (in thousands, except per share amounts):

 

 

 

December 31, 2025

 

 

 

Carrying
Value

 

 

Fair Value

 

 

Conversion
Price

 

Series C-1 Convertible Notes

 

$

3,600

 

 

$

12,461

 

 

$

97.78

 

Series C-2 Convertible Notes

 

 

4,314

 

 

 

21,373

 

 

 

68.32

 

Series D Convertible Notes

 

 

9,300

 

 

 

17,203

 

 

 

183.03

 

 

 

17,214

 

 

$

51,037

 

 

 

 

Unamortized debt discounts

 

—

 

 

 

 

 

 

 

Total Convertible Notes, net

 

$

17,214

 

 

 

 

 

 

 

 

Immediately prior to the closing of the IPO in February 2026, the outstanding Convertible Notes were converted into their respective classes of convertible preferred stock, which then immediately converted into 2,819,512 shares of our common stock. Upon conversion, the carrying values of the Convertible Notes, together with accrued interest, and the related derivative liability, which was remeasured to fair value on the IPO date, were reclassified to additional paid-in capital.

9.
Convertible Preferred Stock

Convertible preferred stock consists of the following for the period indicated (in thousands, except share amounts):

 

 

As of December 31, 2025

 

Convertible Preferred Stock

 

Authorized
Shares

 

 

Issued and
Outstanding
Shares

 

 

Carrying
Value

 

 

Liquidation
Preference

 

Series A-1 convertible preferred stock

 

 

94,010

 

 

 

94,010

 

 

$

3,000

 

 

$

3,001

 

Series A-2 convertible preferred stock

 

 

82,400

 

 

 

82,400

 

 

 

2,395

 

 

 

2,105

 

Series B-1 convertible preferred stock

 

 

374,440

 

 

 

344,730

 

 

 

19,957

 

 

 

20,125

 

Series B-2 convertible preferred stock

 

 

229,258

 

 

 

229,061

 

 

 

16,423

 

 

 

11,366

 

Series C-1 convertible preferred stock

 

 

122,726

 

 

 

85,909

 

 

 

8,293

 

 

 

8,400

 

Series C-2 convertible preferred stock

 

 

157,973

 

 

 

94,825

 

 

 

9,272

 

 

 

6,479

 

Series D convertible preferred stock

 

 

286,498

 

 

 

233,761

 

 

 

42,627

 

 

 

42,785

 

 

 

1,347,305

 

 

 

1,164,696

 

 

$

101,967

 

 

$

94,261

 

 

The Company classified its convertible preferred stock outside of total stockholders’ deficit because, in the event of certain “liquidation events” that are not solely within the control of the Company (including a merger, acquisition or sale of all or substantially all of the Company’s assets), the shares would become redeemable at the option of the holders. The Company did not adjust the carrying values of the convertible preferred stock to the deemed liquidation values of such shares since a liquidation event was not probable at any of the reporting dates. Subsequent adjustments to increase or decrease the carrying values to the ultimate liquidation values will be made only if and when it becomes probable that such liquidation event will occur.

In February 2026, immediately prior to the completion of the IPO, all of the then-outstanding shares of convertible preferred stock automatically converted into 21,779,817 shares of common stock at the applicable conversion ratio then in effect. Upon conversion, the carrying value of the convertible preferred stock was reclassified to common stock and additional paid-in capital.

15


 

10.
Common Stock

In connection with the IPO, in February 2026, the Company filed an amended and restated certificate of incorporation effective immediately prior to the closing of the IPO that authorized the issuance of up to 1,000,000,000 shares of common stock, par value $0.0001 per share, and 100,000,000 shares of preferred stock, par value $0.0001 per share.

The Company had reserved shares of common stock for issuance in connection with the following for the periods indicated on an as-converted basis:

 

 

September 30,

 

 

December 31,

 

 

2026

 

 

2025

 

 

 

 

 

 

 

 

Options outstanding

 

 

5,716,798

 

 

 

5,477,425

 

Options available for future issuance under the 2026 Omnibus Plan

 

 

3,481,959

 

 

 

—

 

Restricted stock units outstanding

 

 

524,375

 

 

 

—

 

Conversion of outstanding shares of convertible preferred stock

 

 

—

 

 

 

21,779,817

 

Convertible Notes

 

 

—

 

 

 

2,819,512

 

Warrants issued to a customer

 

 

—

 

 

 

514,923

 

Convertible Preferred Stock Warrants

 

 

—

 

 

 

141,858

 

Options available for future issuance under the 2021 Plan

 

 

—

 

 

 

58,961

 

Total reserved shares of common stock

 

 

9,723,132

 

 

 

30,792,496

 

 

11.
STOCK-BASED COMPENSATION

For the three months ended September 30, 2026 and 2025, the Company recognized stock-based compensation of approximately $3.0 million and $1.0 million which was recognized in selling, general and administrative expenses in the statements of operations and comprehensive loss. For the nine months ended September 30, 2026 and 2025, the Company recognized stock-based compensation of approximately $12.0 million and $2.9 million, which was recognized in selling, general and administrative expenses in the statements of operations and comprehensive loss.

Stock Options

On February 5, 2026, the board of directors of the Company (“Board of Directors”) adopted, and the Company’s stockholders approved, the omnibus equity incentive plan (the “2026 Omnibus Plan”), which became effective on the same date. The 2026 Omnibus Plan replaced the existing omnibus equity incentive plan (“2021 Plan”), as the Board of Directors determined to not make additional grants under the 2021 Plan following the closing of the IPO. However, the 2021 Plan continues to govern outstanding stock option awards granted under the 2021 Plan. The 2026 Omnibus Plan allows the Company to grant incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance awards and other awards. The number of shares initially available for issuance under awards granted pursuant to the 2026 Omnibus Plan is 4,023,181.

16


 

The following table summarizes the stock option activity for the nine months ended September 30, 2026:

 

 

Stock Options

 

 

Number of
Options
Outstanding

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Life
(Years)

 

 

Aggregate
Intrinsic
Value (In
Thousands)

 

Balances as of December 31, 2025

 

 

5,477,425

 

 

$

3.96

 

 

 

6.8

 

 

$

71,837

 

Options granted

 

 

541,222

 

 

 

17.94

 

 

 

 

 

 

 

Options exercised

 

 

(245,404

)

 

 

3.66

 

 

 

 

 

 

3,171

 

Options forfeited and expired

 

 

(56,445

)

 

 

15.22

 

 

 

 

 

 

 

Balances as of September 30, 2026

 

 

5,716,798

 

 

$

5.19

 

 

 

6.4

 

 

$

61,509

 

Vested and expected to vest as of September 30, 2026

 

 

5,716,798

 

 

$

5.19

 

 

 

6.4

 

 

$

61,509

 

Options exercisable as of September 30, 2026

 

 

4,595,160

 

 

$

3.55

 

 

 

5.8

 

 

$

56,086

 

 

The intrinsic value of options exercised during the three months ended September 30, 2026 and 2025 was $1.9 million and $16.2 million. The intrinsic value of options exercised during the nine months ended September 30, 2026 and 2025 was $3.2 million and $17.6 million. This intrinsic value represents the difference between the fair value of the Company’s common stock on the date of exercise and the exercise price of each option.

During the three months ended September 30, 2026, the weighted average grant date fair value of options granted, was $12.66 per share. There were no options granted during the three months ended September 30, 2025. During the nine months ended September 30, 2026 and 2025, the weighted average grant date fair value of options granted, was $12.66 and $10.30 per share.

During the three months ended September 30, 2026 and 2025, the Company recognized $1.1 million and $1.0 million of stock-based compensation related to stock options. During the nine months ended September 30, 2026, the Company recognized $5.7 million of stock-based compensation related to stock options including $2.6 million of stock-based compensation associated with accelerated vesting of the Spokesperson's (defined in Note 12, Related Party Transactions) stock options upon the closing of the IPO in February 2026. During the nine months ended September 30, 2025, the Company recognized $2.9 million of stock-based compensation related to stock options.

As of September 30, 2026, the unrecognized compensation related to the service-based vesting options is approximately $10.1 million, which will be recognized over a weighted-average remaining requisite service period of 2.8 years. The Company recorded no income tax benefit related to these options for the three and nine months ended September 30, 2026, since the Company currently maintains a full valuation allowance against its net deferred tax assets.

The fair value of each service-based vesting stock option granted during the year was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions:

 

 

Nine Months Ended September 30,

 

2026

 

2025

Risk-free interest rate

 

3.76% - 4.42%

 

4.09%

Expected term (in years)

 

6.04 - 6.25

 

6.02

Expected volatility

 

77.03% - 77.51%

 

76.97%

Dividend yield

 

—%

 

—%

 

17


 

 

Stock Appreciation Rights granted to employees and executives

During the nine months ended September 30, 2025, the Company granted 694,835 stock appreciation rights under the 2021 Plan (the “SARs”) to certain employees and executives with weighted-average exercise prices of $15.77 per share. There were no grants of SARs during the three months ended September 30, 2025.

During the three and nine months ended September 30, 2025, 9,350 and 78,540 of SARs issued to employees were forfeited. As of September 30, 2025 there were 1,148,234 of SARs issued to employees outstanding, with a weighted-average exercise price of $13.36.

On February 5, 2026, the Company approved the cash settlement of vested SARs and the conversion of each outstanding unvested SAR held by participants as of the closing of the IPO into a number of restricted stock units (“Replacement RSUs”) to be issued under the 2026 Omnibus Plan. Accordingly, the Company paid $2.2 million of cash consideration to settle 271,760 vested SARs upon consummation of the IPO, and recognized related stock-based compensation of $2.2 million within selling, general and administrative expenses on the condensed consolidated statement of operations. A total of 992,414 outstanding unvested SARs were converted into 169,366 Replacement RSUs, of which a certain portion vests on the six month anniversary of the IPO date, with the remaining portion vesting in equal quarterly installments across the remaining service period of the original SARs. The aggregate grant date fair value of the Replacement RSUs is $3.0 million, which will be recognized on a straight-line basis over their respective service periods.

Restricted Stock Units

During the three and nine months ended September 30, 2026, the Company granted shares of restricted stock units under the 2026 Omnibus Plan (“RSUs”) to certain employees, executives and directors, including the Replacement RSUs. RSUs granted to employees and executives, other than the SAR Replacement RSUs, generally vest in quarterly installments on each of the first four anniversaries of the date of grant, subject to the grantee's continued service with the Company. RSUs granted to directors generally vest in full on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting following the date of grant, subject to the grantee's continued service with the Company.

The following table summarizes the RSUs activity for the nine months ended September 30, 2026:

 

Number of
RSUs
Outstanding

 

 

Weighted-Average Grant Date FV

 

Unvested RSUs as of December 31, 2025

 

 

—

 

 

$

—

 

Granted

 

 

682,602

 

 

 

17.80

 

Vested

 

 

(117,789

)

 

 

17.46

 

Forfeited

 

 

(40,438

)

 

 

18.00

 

Unvested RSUs as of September 30, 2026

 

 

524,375

 

 

$

17.66

 

During the three and nine months ended September 30, 2026, the Company recognized stock-based compensation of $1.9 million and $4.1 million related to RSUs.

As of September 30, 2026, the total unrecognized stock-based compensation related to the Company’s unvested RSUs was $7.3 million, which is expected to be recognized over a weighted-average period of 2.4 years.

18


 

Stock Appreciation Rights issued to a customer

On March 27, 2025, the Company granted 187,000 SARs to a customer at an exercise price of $19.58 per share. The SARs issued to a customer vest based on the customer achieving specified milestones of sales of the Company’s products over a three year period beginning April 1, 2025 (the “Vesting Period”). Following the Vesting Period, any vested SARs issued to the customer may be exercised by the holder at any time while any unvested SARs issued to the customer will be forfeited. Any vested SARs issued to the customer will be automatically exercised on the earlier of March 27, 2035 or upon the occurrence of a change of control after the end of the Vesting Period. The SARs issued to a customer are liability-classified instruments. Such SARs are recognized as the corresponding revenue is earned, provided it is probable that the performance conditions will be satisfied, and reduce the transaction price of revenue earned under the customer contract based on the grant date fair value of the awards. Vested SARs will be remeasured each period with changes in the fair value of vested SARs recognized in other income (expense), net in the Company's condensed consolidated statement of operations. During the three months ended September 30, 2026 and 2025, 6,452 and 3,272 SARs issued to a customer vested. During the nine months ended September 30, 2026 and 2025, 15,896 and 5,441 SARs issued to a customer vested. As of September 30, 2026, the total of 24,797 SARs issued to a customer were vested. The assumptions used to determine the fair value of the SARs using the Black-Scholes option-pricing model are as follows:

 

 

 

September 30, 2026

 

December 31, 2025

 

Grant Date

Risk-free interest rate

 

5.25%

 

4.18%

 

4.23%

Expected term (in years)

 

8.50

 

9.25

 

10.00

Volatility

 

77.09%

 

77.24%

 

75.57%

Expected dividend yield

 

—%

 

—%

 

—%

 

The aggregate grant date fair value of the SARs issued to a customer is $2.1 million. For the three months ended September 30, 2026 and 2025, the Company recorded $0.1 million and an immaterial amount as a reduction of revenue related to the SARs issued to a customer. For the nine months ended September 30, 2026 and 2025, the Company recorded $0.2 million and $0.1 million as a reduction of revenue related to the SARs issued to a customer. As of September 30, 2026, the liability related to the vested SARs issued to a customer was $0.3 million and was recorded within other non-current liabilities on the Company’s balance sheets. For the three months ended September 30, 2026 and 2025, the Company recorded $0.1 million and an immaterial amount for the changes in the fair value of vested SARs. For the nine months ended September 30, 2026 and 2025, the Company recorded immaterial amounts for the changes in the fair value of vested SARs.

Warrants issued to a customer

During 2018, 2020 and 2024, the Company granted an aggregate 33,046 warrants to a customer to purchase Series B-1 convertible preferred stock, which vested based on the customer achieving defined performance conditions. These warrants issued to a customer were equity-classified instruments and recognized over the applicable vesting period, provided it was probable that the performance conditions would be satisfied, reducing the transaction price of revenue earned under the customer contract. No warrants were issued to customers in the nine months ended September 30, 2026 and 2025.

As of December 31, 2025, 27,536 outstanding warrants issued to a customer were outstanding, all of which were vested. Upon closing of the IPO in February 2026, all of the outstanding convertible preferred stock warrants issued to a customer were net exercised into 438,983 shares of common stock.

19


 

12. Related-Party Transactions

Convertible Notes

At the time the Convertible Notes were issued, the holder held more than 10% of the voting interests in the Company; therefore, meeting the definition of a related party. At no point during the nine months ended September 30, 2026 and 2025, did the holder hold 10% or more of the Company’s voting interests. As such, the holder is not considered a related party for the periods presented.

Spokesperson Transactions

Prior to January 1, 2024, the Company contracted with a Co-Founder and board member (the “Spokesperson”) for personal branding, marketing and promotional services, as well as licensing intellectual property (the “Spokesperson Agreement”). Original compensation included cash payments contingent upon a change in control as defined by the agreement, which includes an IPO, and stock options that accelerated upon such change in control.

In January 2025, the Company amended the agreement with the Spokesperson (the “Amended Spokesperson Agreement”) and added an additional $8.0 million to the contingent cash consideration under the Spokesperson Agreement payable in installments through December 2027, plus additional stock options, for ongoing services. The cash payments and unvested options were to accelerate upon a change in control. Consequently, in connection with the consummation of the Company’s IPO in February 2026, all remaining cash was paid and all unvested options fully vested.

In May 2026, the Amended Spokesperson Agreement was further amended (the “First Amended Spokesperson Agreement”) to add $3.0 million of cash payments payable in equal installments through January 2028 for advertising, marketing, and promotional activities. In the event of a change in control, termination without cause, or resignation for good reason, each as defined by the agreement, all unpaid cash accelerates in full and must be paid to the Spokesperson.

Cash consideration is expensed on a straight-line basis over the requisite service period. Compensation expense recognized in selling, general and administrative expenses on a straight-line basis over the requisite service period related to cash payments made to the Spokesperson were $0.3 million and $0.6 million for the three months ended September 30, 2026 and 2025. For the nine months ended September 30, 2026, the Company recognized $6.1 million of expense related to cash payments made to the Spokesperson. These cash payments included $7.0 million of contingent cash consideration triggered by the IPO in February 2026. For the nine months ended September 30, 2025, the Company recognized $1.9 million related to cash payments made to the Spokesperson.

Share-based Compensation

The Spokesperson holds stock options from the agreements referenced above and through grants awarded in the normal course of business and the related expense is recorded within selling, general and administrative expense on the Company’s condensed consolidated statement of operations. Stock-based compensation for stock options granted to the Spokesperson was no amount and $0.3 million for the three months ended September 30, 2026 and 2025, and $2.6 million and $0.8 million for the nine months ended September 30, 2026 and 2025.

IPO Bonus

In May 2026, the Company paid a $1.0 million one-time bonus to the Spokesperson in connection with the IPO that was included in selling, general and administrative expenses in the condensed consolidated statement of operations. The Company also reimbursed the Spokesperson $0.2 million for expenses incurred in connection with the IPO during the nine months ended September 30, 2026.

20


 

13.
segment reporting

The Company operates as a single operating segment, as the Chief Operating Decision Maker (“CODM”) reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. All of the Company’s long-lived assets are located in the United States and less than 1% of the Company’s net sales are from customers located outside the United States.

The CODM uses net loss to assess performance, evaluate cost optimization, and allocate financial, capital and personnel resources. The CODM reviews segment assets on a consolidated basis as presented on the Company’s balance sheet.

The following table sets forth significant expense categories and other specified amounts included in net loss that are reviewed by the CODM, or are otherwise regularly provided to the CODM (in thousands):

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Net sales

 

$

89,067

 

 

$

66,036

 

 

$

247,179

 

 

$

176,656

 

Less:

 

 

 

 

 

 

 

 

 

 

 

 

Cost of goods sold1

 

 

56,565

 

 

 

38,081

 

 

 

153,750

 

 

 

104,879

 

Marketing

 

 

10,592

 

 

 

8,429

 

 

 

36,234

 

 

 

25,323

 

Payroll expenses

 

 

8,093

 

 

 

6,486

 

 

 

25,972

 

 

 

18,039

 

Outbound freight

 

 

4,009

 

 

 

3,369

 

 

 

11,362

 

 

 

9,851

 

Selling expenses

 

 

3,359

 

 

 

3,199

 

 

 

10,702

 

 

 

8,480

 

Warehousing & distribution

 

 

2,189

 

 

 

1,698

 

 

 

6,731

 

 

 

4,696

 

General and administrative costs

 

 

8,147

 

 

 

5,281

 

 

 

26,639

 

 

 

14,315

 

Other segment items2

 

 

(74

)

 

 

10,748

 

 

 

363

 

 

 

30,832

 

Segment net loss

 

$

(3,813

)

 

$

(11,255

)

 

$

(24,574

)

 

$

(39,759

)

 

1.
Cost of goods sold excludes depreciation and amortization.
2.
Other segment items is primarily comprised of depreciation and amortization expense, interest income, interest expense, change in fair value of derivative liabilities, change in fair value of convertible preferred stock warrant liabilities, provision for income taxes and product development costs.
14.
Net loss per share

The following outstanding balances of securities have been excluded from the calculation of diluted weighted average common shares outstanding and diluted net loss per share because the effect of including them would have been antidilutive.

 

 

Three and Nine Months Ended September 30,

 

 

2026

 

 

2025

 

Stock options

 

 

5,716,798

 

 

 

5,477,425

 

Restricted stock units

 

 

524,375

 

 

 

—

 

Convertible preferred stock

 

 

—

 

 

 

21,779,817

 

Convertible Notes

 

 

—

 

 

 

2,819,512

 

Warrants issued to a customer

 

 

—

 

 

 

514,923

 

Convertible Preferred Stock Warrants

 

 

—

 

 

 

141,858

 

Total common shares equivalent

 

 

6,241,173

 

 

 

30,733,535

 

 

21


 

15. SuBsequent Events

On October 30, 2026, the Company announced a voluntary recall and reformulation (the "Recall") of all of its Tractor Wheels soft-baked bars ("Tractor Wheels") due to reported choking incidents. The Company has temporarily suspended shipments of Tractor Wheels and is preparing production plans to support a return to shelf for Tractor Wheels as soon as possible, once an evaluation is complete and any necessary changes for product safety have been implemented and validated. For the nine months ended September 30, 2026, Tractor Wheels accounted for approximately 18% of the Company's net sales. As of October 31, 2026, the Company had inventory related to Tractor Wheels of approximately $7.9 million, consisting of raw material, packaging and finished goods, before any adjustments for net realizable value or obsolescence. The Company's condensed consolidated financial statements as of and for the three and nine months ended September 30, 2026 do not reflect any adjustments related to the Recall, which the Company has determined to be a nonrecognized subsequent event and will be accounted for in the period that the announcement was made.

The Company is currently assessing the financial impact of the Recall, which may include inventory write-downs, product disposition costs, customer refunds, consumer refunds, and operational and other Recall-related costs, net of any insurance or third-party recoveries. The Company is unable to reasonably estimate the financial impact at this time, but expects the Recall to have a significant impact on its results of operations and cash flows for the year ending December 31, 2026 and potentially subsequent periods.

 

 

22


 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those discussed in the forward-looking statements as a result of various factors, including those set forth in Part II, Item 1A. “Risk Factors,” and “Cautionary Statement Concerning Forward-Looking Statements” in this Quarterly Report on Form 10-Q. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q and our audited consolidated financial statements and related notes as disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Annual Report”), filed with the Securities and Exchange Commission (“SEC”) on March 16, 2026.

Overview

Once Upon a Farm is driving systemic change in childhood nutrition with real, organic, farm-fresh food made with no added sugar, no preservatives, and nothing artificial. From baby’s first bites to kid’s school-ready snacks, we are a rapidly growing leader in modern childhood nutrition that provides innovative, nutrient-packed, delicious food to on-the-go parents for their babies and kids. We revolutionized the childhood nutrition category with what we believe is the first-ever cold-pressed Pouch, setting a new standard for nutrition that parents love and kids crave. Our mission and commitment to our consumers guide every decision we make and are at the heart of our identity and journey ahead. We are a Public Benefit Corporation, which requires us to uphold high social and environmental standards and provide transparency for all of our stockholders. Additionally, we believe we are the first baby through kid parent-ally brand with a deep commitment to superior, fresh products with high nutritional standards and incredible taste. Our thoughtful recipes are crafted with high-quality organic ingredients, from cold-pressed Pouches, to Refrigerated Oat Bars and shelf-stable snacks, earning us the trust of parents, and fostering a loyal, passionate, and fast-growing consumer base.

In February 2026, we closed the initial public offering (“IPO”) of our common stock, in which we issued and sold an aggregate of 7,631,537 shares of common stock at a price to the public of $18.00 per share. Shortly following the close of the offering, the underwriters exercised their option to purchase an additional 1,649,581 shares at the initial public offering price. In the aggregate, we received net proceeds from the offering of approximately $138.5 million, after deducting underwriting discounts, commissions and offering expenses.

Recent Developments

On October 30, 2026, we announced a voluntary recall and reformulation (the “Recall”) of all our Tractor Wheels soft-baked bars ("Tractor Wheels") due to reported choking incidents. We have temporarily suspended shipments of Tractor Wheels and we are preparing production plans to support a return to shelf for Tractor Wheels as soon as possible, once an evaluation is complete and any necessary changes for product safety have been implemented and validated. Our financial results for the nine months ended September 30, 2026 do not reflect any adjustments related to the Recall.

For the nine months ended September 30, 2026, Tractor Wheels accounted for approximately 18% of our net sales. As of October 31, 2026, our inventory related to Tractor Wheels was approximately $7.9 million, consisting of raw material, packaging and finished goods, before any adjustments for obsolescence or net realizable value. Because Tractor Wheels represented a significant portion of our net sales and shipments have been temporarily suspended, we currently expect the Recall to have a significant impact on our net sales, gross profit, operating results and cash flows for the fourth quarter of 2026 and potentially subsequent periods. The magnitude and duration of this impact will depend on, among other things, the length of time Tractor Wheels remain off shelf, the timing and cost of completing our evaluation, reformulation, validation and return-to-shelf activities, retailer acceptance and timing of product relaunch, consumer response to the Recall and reformulated product, the amount and timing of inventory write-downs, product disposition costs, consumer and customer refunds, operational and professional costs, and the extent and timing of any insurance or third-party recoveries. The Company will account for the impact of the Recall in the period in which the recall was announced.

23


 

We are currently assessing the total financial impact of the recall, which may include product costs, consumer and customer refunds, and Recall-related costs and are unable to reasonably estimate the full financial impact at this time. For additional information, see Note 15, Subsequent Events, to our unaudited condensed consolidated financial statements in Part I, Item 1. in this Quarterly Report on Form 10-Q, and Part II, Item 1A. “Risk Factors” of this Quarterly Report

Key Factors Affecting our Performance

Our ability to achieve sustainable growth and profitability is impacted by many factors, including those described below. Certain factors are strategically tied to key metrics that define our success:

Increasing Brand Awareness and Household Penetration

Growing our brand awareness and household penetration is central to our strategy for long-term growth. Our approach and creation of great-tasting, high-quality, nutritional and organic products that kids love establishes trust in parents and fosters brand-loyalty from our customers. As we continue to expand our innovative product offerings, we plan to establish trust with parents in the early stages of their baby’s development, building brand loyalty that allows us to strategically deliver great-tasting, healthy and convenient products to kids of all ages. We plan to increase our brand awareness and household penetration by leveraging a full-funnel modern marketing approach that includes retail media networks, influencer programs, high-frequency national media campaigns, engaging social media, impactful sponsorships, and immersive activations. To grow and maintain our brand, we must invest in sales and marketing to promote word-of-mouth sharing of our brand to attract new customers. We believe that once consumers are introduced to our brand and products, we will be able to drive conversion to repeat purchases and long-term loyalty.

Investment in Retail Partnerships and Distribution Expansion

Our long-term growth strategy relies on our ability to cultivate and maintain relationships with our retail customers to expand our presence and optimize distribution across all retail stores. Our success is dependent on deepening the assortment of our product offerings and ensuring that our products are prominently displayed in both our retail customers’ brick-and-mortar stores and e-commerce platforms. Our relationships with our retail customers also allow us to deepen the assortment of our product offerings by extending our reach to new product categories and expanding the number of shelves that our products are displayed on at stores in major classes of retail, including grocery, mass, club, natural and specialty stores.

We also intend to grow our sales and in-store footprint through the expansion and productivity of our cooler program. Our coolers, which can be found replacing standard shelving in the baby aisle, as an end-cap display or free standing in the baby aisle, currently feature our widest selection of Baby Pouches and our new Meat, Meat & Bone Broth and Legume Blend pouches introduced in the quarter ended June 30, 2026. As of September 30, 2026, we have deployed over 4,600 coolers in stores to date and believe there may be an opportunity to expand the footprint to more than 15,000 coolers in stores in North America. We invest in slotting fees and offer other incentives to encourage our retail customers to place our coolers in more of their stores and display our coolers in ideal locations within their stores. As we accelerate the expansion and productivity of our cooler program, we expect to continue to see increases in overall sales velocity and believe there are further opportunities for sales velocity enhancement as our cooler base matures and we continue to optimize the product assortment offered in the cooler and encourage excitement for our product across aisles. The presence of baby coolers also drives an increase in basket size for the whole baby department, which encourages our retail customers to participate in this initiative with us. The direct impact of the new cooler additions on our net sales varies based on numerous factors including store traffic and cooler size.

In addition to our primary retail growth strategy of increasing depth of our product offerings with our existing retail customers, we believe there is a significant opportunity to increase sales through e-commerce and delivery platforms and expand into new retail customers and international markets.

24


 

Product Innovation and Category Leadership

We are confident that through innovation in new products, product line extensions, and packaging types, we will drive meaningful growth for our Company. Investment in strategic product innovation is vital for meeting evolving consumer needs and complementing our existing product portfolio to expand our brand’s reach. We continue to expand and enhance our product offerings, including launches of Refrigerated Oat Bars and shelf-stable snacks. During 2026 we've introduced Meat, Meat & Bone Broth, and Legume Blend pouches as well as refrigerated Electrolyte Blends pouches, to meet the evolving needs of our consumers and drive demand for our products.

Aligning our innovation pipeline with consumer demands for organic, nutritious, delicious, and convenient products has positioned us as a leader in the baby and kids’ food market. We plan to invest in exploring new flavor combinations and innovative formats that enhance taste and nutritional value, and in expanding our existing functional product offerings across various formats, such as immunity, brain health, and protein, to provide parents with the functionality they are looking for and satisfy the cravings of babies and kids.

Drive Sustainable, Profitable Growth

Our future success is dependent on our ability to drive sustainable and profitable growth. We have made significant investments in assembling our strong leadership team, implementing strategic sales management principles, and building our global procurement network infrastructure to support long-term growth and to enhance the profitability of our core operating model as we grow. We also plan to continue to invest in expansion and automation of our scalable production platform with our co-manufacturing partners to increase our capacity and operational efficiency to support our growth and achieve economies of scale. With these investments, we believe we will be well-positioned to consistently deliver the highest quality, premium products to our consumers while also ensuring profitability and sustainability.

As we extend our presence with existing retail customers, we believe there may also be opportunity to further increase our operating margins. The strength of our brand and ability to efficiently deliver industry-disrupting products to our consumers have consistently resulted in attractive gross margins.

Macroeconomic and Geopolitical Uncertainty and Supply Chain Costs

Uncertainty in the macroeconomic environment resulting from geopolitical and economic instability, including the imposition of tariffs, embargoes, or similar restrictions could cause disruption in our supply chain. For example, in 2025, the U.S. presidential administration announced the imposition of tariffs on numerous countries that trade with the United States, and in February 2026 the United States Supreme Court issued a ruling striking down certain tariffs previously imposed under the International Emergency Economic Powers Act (“IEEPA”). Following the Supreme Court’s decision, the U.S. presidential administration announced its intention to invoke other laws to collect tariffs and announced new tariffs on imports from all countries, in addition to any existing non-IEEPA tariff. On July 24, 2026, the U.S. presidential administration imposed additional tariffs on certain imports, further contributing to the evolving and uncertain tariff landscape. As the implementation of tariffs is ongoing, more tariffs may be added in the future and countermeasures may be adopted by other countries.

Following the February 2026 ruling, and effective on April 20, 2026, the U.S. Customs and Border Protection launched a platform for importers of record to begin submitting IEEPA tariff refund requests. The imposition of new tariffs (or uncertainty regarding the timing and amount of any tariff refund payments) remains uncertain as the situation is dynamic and rapidly evolving. See Note 2 (Summary of Significant Accounting Policies – Vendor Rebates) of our unaudited condensed consolidated financial statements. New or increased tariffs could also negatively affect U.S national or regional economies or lead to increased inflation or a recession, which also could negatively impact our sales growth, and our business and results of operations. Any tariffs or other barriers to trade affecting Mexico and South America in particular, two regions from which we source a significant portion of our key fruit and vegetable ingredients, could lead to, among other things, shortages and higher cost of procurement, and could negatively impact our business and profitability.

In addition, in recent years, we have experienced elevated commodity and supply chain costs, including the costs of raw materials, packaging, labor, energy, fuel, freight, and other inputs necessary for the production and

25


 

distribution of our products, and we expect elevated levels of inflation to continue in 2026. In particular, fuel costs have been subject to heightened volatility due to persistent inflationary pressures and ongoing geopolitical uncertainty, including disruptions to global energy markets. Such elevated commodity and supply chain costs and inflation levels did not have a material impact on our results of operations for the three and nine months ended September 30, 2026 and 2025, however, there can be no assurance that continued volatility in fuel costs driven by inflationary conditions or geopolitical developments will not have a material effect on our results of operations or financial condition in future periods. In an effort to mitigate the impact of these elevated costs, we have taken actions to: diversify the regions from which we source the raw materials used in our business, remove intermediate third parties in our supply chain, scale our business and work with co-manufacturing partners to increase our capacity and operational efficiency, including through investment in equipment used by our co-manufacturers. We also continue to monitor fuel cost trends and evaluate strategies to mitigate the impact of fuel price volatility on our operations, including optimizing distribution routes and logistics arrangements and, where appropriate, negotiating fuel surcharge provisions in our transportation contracts.

For a further discussion of the risks and challenges posed by these events, see Part II, Item 1A. “Risk Factors—Risks Relating to Our Business and Industry” in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, and Part I, Item 1A. “Risk Factors—Risks Relating to Our Business and Industry” in our Annual Report on Form 10-K.

Components of Results of Operations

Net Sales

We generate revenue through sales of organic, nutrient-packed, farm-fresh Pouches, snacks, and other products for babies and kids through retail channels, which include traditional brick-and-mortar stores, e-commerce platforms, and delivery platforms, as well as directly to consumers through our direct-to-consumer (“DTC”) platform that we operate. Our revenue is recognized net of allowances for sales discounts and promotions and any sales or other similar taxes collected from consumers. We offer sales discounts and promotions to our retail and DTC customers through various programs. These programs include sales incentives, trade allowances, slotting fees, coupon offers, rebates, and term discounts. We anticipate that these sales discounts and promotions will impact our net sales and that changes in these activities could impact period over period results.

Cost of Goods Sold

Cost of goods sold consists primarily of product costs, third-party manufacturing fees, inbound freight of raw materials and finished goods, storage and handling costs during the manufacturing process, product loading and handling at our outsourced production facilities for distribution, depreciation of machinery, and equipment used in the manufacturing process as well as duties and tariffs.

We source our organic raw materials from farmers both in the United States and international markets. We also contract with outsourced partners in the United States to manufacture, package, and distribute our products to our customers.

Gross Profit and Gross Margin

Gross profit represents net sales less cost of goods sold. Gross margin is gross profit expressed as a percentage of net sales.

Our gross margin may in the future fluctuate from period to period based on a number of factors, including costs of produce and commodities, manufacturing, warehousing and transportation rates for inbound raw materials. Gross margin may also fluctuate in the future based on changes in the promotional environment in the marketplace, the expansion of our cooler program, the mix of products we sell, the channel through which we sell our products and innovation initiatives we undertake in each of our product categories, among other factors.

26


 

Selling, General and Administrative

Selling, general and administrative expenses primarily consist of payroll and payroll-related benefits, stock-based compensation, marketing content and agency fees, customer growth and acquisition costs, warehouse and distribution costs, and freight costs associated with shipping goods to customers. Selling, general and administrative expenses also include depreciation and amortization and product development costs.

We expect selling, general and administrative expenses to increase in the future as we continue to scale our operations to meet our product demand, continue to build our product portfolio, and add personnel to our organization. We also expect to incur additional costs associated with operating as a public company, including increased expenses related to legal, audit, accounting, regulatory, and tax-related services associated with maintaining compliance with exchange listing and SEC requirements, director and officer insurance costs, investor and public relations costs, and other administrative and professional services.

Other Income (Expense)

Interest income consists of interest earned on our cash and cash equivalents. Interest expense is attributable to interest on our outstanding borrowings under our Nonconvertible Debt and Convertible Notes agreements (each as defined below). Following our initial public offering, we expect our interest expense to decrease, as a portion of the proceeds from the initial public offering were used to repay borrowings then outstanding under the Revolving Credit Facility and our outstanding Convertible Notes were converted into shares prior to or at the time of the offering. However, our Revolving Credit Facility provides for availability of up to $65.0 million of borrowings and our Term Loan Facility for availability of up to $30.0 million. From time to time, we may draw amounts under our Revolving Credit Facility and our Term Loan Facility and expect to incur interest expense as a result of any such draws.

Change in fair value of derivative liability consists of adjustments to the fair value of our derivative liability. As a result of our initial public offering in February 2026 and the conversion of our outstanding Convertible Notes into shares of common stock, the derivative liability was eliminated and there will be no subsequent change in its fair value.

Other income (expense), net primarily consists of gains or losses due to adjustments to the fair value of our convertible preferred stock warrant liability. Subsequent to our initial public offering, the convertible preferred stock warrant liability was eliminated as a result of the exercise of the underlying warrants, and there will be no subsequent changes in its fair value.

27


 

Results of Operations

 

Comparison of the Three and Nine Months Ended September 30, 2026 and 2025

The results of operations data have been derived from the unaudited condensed consolidated financial statements included in Part I, Item 1. in this Quarterly Report on Form 10-Q. The following table sets forth our results of operations for the periods presented:

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

2026

 

 

2025

 

 

2026

 

 

2025

 

(in thousands)

 

Net sales

$

89,067

 

 

$

66,036

 

 

$

247,179

 

 

$

176,656

 

Cost of goods sold

 

56,915

 

 

 

38,251

 

 

 

154,700

 

 

 

105,325

 

Gross profit

 

32,152

 

 

 

27,785

 

 

 

92,479

 

 

 

71,331

 

Selling, general and administrative

 

36,808

 

 

 

28,837

 

 

 

118,924

 

 

 

81,550

 

Loss from operations

 

(4,656

)

 

 

(1,052

)

 

 

(26,445

)

 

 

(10,219

)

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

(50

)

 

 

(801

)

 

 

(519

)

 

 

(1,984

)

Interest income

 

866

 

 

 

59

 

 

 

2,200

 

 

 

253

 

Change in fair value of derivative liability

 

—

 

 

 

(8,460

)

 

 

340

 

 

 

(26,320

)

Other income (expense), net

 

54

 

 

 

(462

)

 

 

(81

)

 

 

(1,447

)

Total other income (expense)

 

870

 

 

 

(9,664

)

 

 

1,940

 

 

 

(29,498

)

Net loss before income tax provision

 

(3,786

)

 

 

(10,716

)

 

 

(24,505

)

 

 

(39,717

)

Income tax provision

 

(27

)

 

 

(539

)

 

 

(69

)

 

 

(42

)

Net loss

$

(3,813

)

 

$

(11,255

)

 

$

(24,574

)

 

$

(39,759

)

 

Net Sales

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2026

 

 

2025

 

 

$
Change

 

 

%
Change

 

 

2026

 

 

2025

 

 

$
Change

 

 

%
Change

 

 

(dollars in thousands)

 

 

 

 

 

(dollars in thousands)

 

 

 

 

Kid

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pouches

 

$

37,473

 

 

$

29,956

 

 

$

7,517

 

 

 

25

%

 

$

103,121

 

 

$

88,159

 

 

$

14,962

 

 

 

17

%

Snacks

 

 

4,767

 

 

 

6,163

 

 

 

(1,396

)

 

 

(23

)%

 

 

17,179

 

 

 

16,433

 

 

 

746

 

 

 

5

%

Total Kid

 

 

42,240

 

 

 

36,119

 

 

 

6,121

 

 

 

17

%

 

 

120,300

 

 

 

104,592

 

 

 

15,708

 

 

 

15

%

Baby

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pouches

 

 

11,608

 

 

 

9,634

 

 

 

1,974

 

 

 

20

%

 

 

34,371

 

 

 

21,595

 

 

 

12,776

 

 

 

59

%

Snacks

 

 

34,818

 

 

 

19,766

 

 

 

15,052

 

 

 

76

%

 

 

91,229

 

 

 

48,650

 

 

 

42,579

 

 

 

88

%

Other

 

 

401

 

 

 

517

 

 

 

(116

)

 

 

(22

)%

 

 

1,279

 

 

 

1,819

 

 

 

(540

)

 

 

(30

)%

Total Baby

 

 

46,827

 

 

 

29,917

 

 

 

16,910

 

 

 

57

%

 

 

126,879

 

 

 

72,064

 

 

 

54,815

 

 

 

76

%

Net sales

 

$

89,067

 

 

$

66,036

 

 

$

23,031

 

 

 

35

%

 

$

247,179

 

 

$

176,656

 

 

$

70,523

 

 

 

40

%

 

For the three months ended September 30, 2026, net sales increased $23.0 million, or 35%, compared to the three months ended September 30, 2025, primarily due to an increase in volume growth of more than 32%, driven by both the incremental distribution of existing products and the introduction of new products into our portfolio. Additionally, since 2025, we have launched 99 new SKUs across categories, with 8 new SKUs introduced during the three months ended September 30, 2026. A “new SKU” is a unique product configuration, represented by a distinct GTIN/UPC, or barcode, that differs from existing SKUs in formulation, flavor, size, or format, and is introduced for commercial sale in our markets for the first time. Our snacks categories resulted in a net increase of $13.7 million, or 53%, increase in net sales period over period. Net sales from Pouches increased by $9.5 million, or 24% period over period. Our trade spending, which includes sales incentives, trade allowances, term discounts, and slotting fees, and is recognized as a reduction of net sales, increased for the three months ended September 30,

28


 

2026 compared to three months ended September 30, 2025 primarily due to promotional programs for increased distribution of our products and introduction of new products. For the three months ended September 30, 2026 and 2025, we incurred $3.6 million and $1.1 million in trade spending related to slotting fees paid to retail customers for placement of new coolers in their stores. The slotting fees paid related to placement of new coolers in stores increased compared to three months ended September 30, 2025 due to timing of installation of coolers in stores.

 

For the nine months ended September 30, 2026, net sales increased $70.5 million, or 40%, compared to the nine months ended September 30, 2025, primarily due to an increase in volume growth of more than 31%, driven by both the incremental distribution of existing products and the introduction of new products into our portfolio. The increase in net sales was also driven by a more favorable product mix. We have launched 54 new SKUs introduced during the nine months ended September 30, 2026. Our snacks categories resulted in a combined $43.3 million, or 67%, increase in net sales period over period. Net sales from Pouches increased by $27.7 million, or 25%, period over period. For the nine months ended September 30, 2026 and 2025, we incurred $5.7 million and $6.7 million in trade spending related to slotting fees paid to retail customers for placement of new coolers in their stores, which was recognized as a reduction of net sales. The slotting fees paid related to placement of new coolers in stores decreased compared to nine months ended September 30, 2025 due to timing of installation of coolers in stores; however, these slotting fees are expected to increase in the future as we continue the expansion of our baby cooler program and increase our presence in our retail customers' stores.

Cost of Goods Sold

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

2026

 

 

2025

 

 

$
Change

 

 

%
Change

 

 

2026

 

 

2025

 

 

$
Change

 

 

%
Change

 

(dollars in thousands)

 

 

 

 

 

(dollars in thousands)

 

 

 

 

Cost of goods sold

$

56,915

 

 

$

38,251

 

 

$

18,664

 

 

 

49

%

 

$

154,700

 

 

$

105,325

 

 

$

49,375

 

 

 

47

%

Percentage of net sales

 

64

%

 

 

58

%

 

 

 

 

 

6

%

 

 

63

%

 

 

60

%

 

 

 

 

 

3

%

 

For the three months ended September 30, 2026, cost of goods sold increased $18.7 million, or 49%, compared to three months ended September 30, 2025, primarily due to increased sales volume. Cost of goods sold as a percentage of net sales increased by 6% primarily due to increased trade spending, which was recognized as a reduction of net sales, and a less favorable product mix. The increase in trade spending was primarily driven by slotting fees paid for the placement of new coolers in stores and by promotional programs supporting increased distribution of our products.

 

For the nine months ended September 30, 2026, cost of goods sold increased $49.4 million, or 47%, compared to nine months ended September 30, 2025, primarily due to increased sales volume. Cost of goods sold as a percentage of net sales increased by 3% primarily due to less favorable product mix, partially offset by pricing and favorable customer mix.

Gross Profit and Gross Margin

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

2026

 

 

2025

 

 

$
Change

 

 

%
Change

 

 

2026

 

 

2025

 

 

$
Change

 

 

%
Change

 

(dollars in thousands)

 

 

 

 

 

(dollars in thousands)

 

 

 

 

Gross profit

$

32,152

 

 

$

27,785

 

 

$

4,367

 

 

 

16

%

 

$

92,479

 

 

$

71,331

 

 

$

21,148

 

 

 

30

%

Gross margin

 

36

%

 

 

42

%

 

 

 

 

 

(6

)%

 

 

37

%

 

 

40

%

 

 

 

 

 

(3

)%

 

For the three months ended September 30, 2026, gross profit increased $4.4 million, or 16%, compared to the three months ended September 30, 2025, due to higher net sales. The decrease in gross margin of 6% for the three months ended September 30, 2026, compared to the three months ended September 30, 2025 was primarily driven by increased cost of goods sold as a percentage of net sales, which resulted from increased trade spending and a less favorable product mix.

29


 

For the nine months ended September 30, 2026, gross profit increased $21.1 million, or 30% compared to the nine months ended September 30, 2025, due to higher net sales. The decrease in gross margin of 3% for the nine months ended September 30, 2026, compared to the nine months ended September 30, 2025 was primarily driven by increased cost of goods sold as a percentage of net sales, which resulted from a less favorable product mix.

Selling, General and Administrative

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

2026

 

 

2025

 

 

$
Change

 

 

%
Change

 

 

2026

 

 

2025

 

 

$
Change

 

 

%
Change

 

(dollars in thousands)

 

 

 

 

 

(dollars in thousands)

 

 

 

 

Selling, general and administrative

$

36,808

 

 

$

28,837

 

 

$

7,971

 

 

 

28

%

 

$

118,924

 

 

$

81,550

 

 

$

37,374

 

 

 

46

%

Percentage of net sales

 

41

%

 

 

44

%

 

 

 

 

 

(3

)%

 

 

48

%

 

 

46

%

 

 

 

 

 

2

%

 

For the three months ended September 30, 2026, selling, general and administrative expenses increased by $8.0 million, or 28%, compared to the three months ended September 30, 2025, primarily due to:

•
an increase of $2.2 million in marketing expenses, primarily due to increased advertising expenditures to expand our advertising footprint;
•
an increase of $2.0 million in stock-based compensation driven by increase in headcount and awards granted in connection with our IPO;
•
an increase of $1.6 million in employee-related costs, driven by an overall increase in headcount to support our continued growth;
•
an increase of $1.1 million in warehouse and distribution expenses and higher outbound freight driven by higher sales volumes and carrying larger volumes of inventory on hand throughout the period to support our growth; and
•
an increase of $1.1 million in general and administrative expenses, primarily related to travel, depreciation and other expenses to support our increase in headcount and continued growth.

 

For the nine months ended September 30, 2026, selling, general and administrative expenses increased by $37.4 million, or 46%, compared to the nine months ended September 30, 2025, primarily due to:

•
an increase of $10.9 million in marketing expenses, primarily related to $5.4 million of expense related to cash paid to the Spokesperson in connection with our IPO, and increased advertising expenditures, related to production costs and increasing our advertising footprint;
•
an increase of $9.1 million in stock-based compensation, primarily driven by $4.1 million of expense related to restricted stock units, which were granted in the period, as well as $2.6 million of expense related to accelerated vesting of certain of the Spokesperson's stock options, and $2.2 million of expense related to the cash settlement of vested stock appreciation rights, both in connection with our IPO, which closed in February 2026;
•
an increase of $7.9 million in employee-related costs, driven by an overall increase in headcount to support our continued growth, including an aggregate of $0.7 million of one-time transaction bonuses paid to certain employees in connection with our IPO;
•
an increase of $3.8 million in general and administrative expenses, consisting of $2.8 million in travel, professional services, depreciation and other expenses to support our increase in headcount and continued growth, and a cash bonus of $1.0 million paid to the Spokesperson related to our IPO;
•
an increase of $3.5 million in warehouse and distribution expenses and higher outbound freight driven by higher sales volumes and carrying larger volumes of inventory on hand throughout the year to support our growth; and

30


 

•
an increase of $2.2 million in selling expenses, primarily driven by increases in merchandising fees, third-party commissions and other customer growth and acquisition costs, to support our growth in sales volume.

Other Income (Expense)

Interest Expense

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

2026

 

 

2025

 

 

$
Change

 

 

%
Change

 

 

2026

 

 

2025

 

 

$
Change

 

 

%
Change

 

(dollars in thousands)

 

 

 

 

 

(dollars in thousands)

 

 

 

 

Interest expense

$

(50

)

 

$

(801

)

 

$

751

 

 

 

(94

)%

 

$

(519

)

 

$

(1,984

)

 

$

1,465

 

 

 

(74

)%

 

For the three months ended September 30, 2026, interest expense decreased $0.8 million, or 94%, compared to the three months ended September 30, 2025. For the nine months ended September 30, 2026, interest expense decreased $1.5 million, or 74%, compared to the nine months ended September 30, 2025. These decreases in interest expense were due to repayment of borrowings in February 2026.

Interest Income

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

2026

 

 

2025

 

 

$
Change

 

 

%
Change

 

 

2026

 

 

2025

 

 

$
Change

 

 

%
Change

 

(dollars in thousands)

 

 

 

 

 

(dollars in thousands)

 

 

 

 

Interest income

$

866

 

 

$

59

 

 

$

807

 

 

 

1,368

%

 

$

2,200

 

 

$

253

 

 

$

1,947

 

 

 

770

%

For the three months ended September 30, 2026, interest income increased $0.8 million, or 1,368% compared to the three months ended September 30, 2025. For the nine months ended September 30, 2026, interest income increased $1.9 million, or 770%, compared to the nine months ended September 30, 2025. These increases in interest income are due to higher average cash balances in our money market accounts, driven by IPO proceeds received in February 2026.

Change in Fair Value of Derivative Liability

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

2026

 

 

2025

 

 

$
Change

 

 

%
Change

 

2026

 

 

2025

 

 

$
Change

 

 

%
Change

(dollars in thousands)

 

 

 

 

(dollars in thousands)

 

 

 

Change in fair value of derivative liability

$

—

 

 

$

(8,460

)

 

$

8,460

 

 

**

 

$

340

 

 

$

(26,320

)

 

$

26,660

 

 

**

** not meaningful

For the three and nine months ended September 30, 2026, there was no change and a $0.3 million change in fair value of our derivative liability as immediately prior to the IPO in February 2026, our Convertible Notes converted into their respective classes of convertible preferred stock, which then immediately converted into shares of our common stock. For the three and nine months ended September 30, 2025, the change in fair value of our derivative liability was driven by a change in fair value of our convertible preferred stock underlying the convertible notes.

31


 

Other Income (Expense), Net

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

2026

 

 

2025

 

 

$
Change

 

 

%
Change

 

 

2026

 

 

2025

 

 

$
Change

 

 

%
Change

 

(dollars in thousands)

 

 

(dollars in thousands)

 

Other income (expense), net

$

54

 

 

$

(462

)

 

$

516

 

 

 

(112

)%

 

$

(81

)

 

$

(1,447

)

 

$

1,366

 

 

 

(94

)%

For the three months ended September 30, 2026, change in other income (expense), net of $0.5 million, compared to the three months ended September 30, 2025, was primarily due to the absence of changes in the fair value of the convertible preferred stock warrant liability during the three months ended September 30, 2026, as the warrants were settled upon the closing of the IPO in February 2026.

 

For the nine months ended September 30, 2026, change in other expense, net of $1.4 million, compared to the nine months ended September 30, 2025, was primarily due to a decrease in the change in fair value of our convertible preferred stock warrant liability and its settlement upon the closing of the IPO in February 2026.

Liquidity and Capital Resources

On February 9, 2026, we completed an IPO in which we issued and sold 7,631,537 shares of common stock, at the public offering price of $18.00 per share, plus an additional 1,649,581 shares of common stock at a public offering price of $18.00 per share pursuant to the exercise of the underwriters’ option to purchase additional shares. We received net proceeds of approximately $138.5 million from the IPO, after deducting underwriting discounts and commissions and offering expenses payable by us. Historically, we have generated operating losses and have relied on private sales of securities and proceeds from debt financing to fund our operations. As of September 30, 2026, we had cash and cash equivalents of $106.4 million and accumulated deficit of $160.3 million. For the three and nine months ended September 30, 2026, we incurred a net loss of $3.8 million and $24.6 million and net cash flow used in operating activities totaled $4.6 million during the nine months ended September 30, 2026. We expect that our existing cash and cash equivalents, along with available borrowing capacity under the Revolving Credit Facility and Term Loan Facility, will be sufficient to support our operations for at least the next 12 months as well as to meet our cash requirements for the longer term.

Our future capital requirements will depend on many factors, including our pace of new and existing customer growth, our investments in innovation, our investment in cooler placements at retail stores, our investments in partnerships, the financial impact of the recently announced product recall and unexplored channels. We may be required to seek additional equity or debt financing. There can be no assurance that additional equity or debt financing will be available to us at terms acceptable to us, or at all and such financing will be impacted by many factors, including the liquidity of the overall capital markets and the future state of the U.S. and global economy.

Nonconvertible Debt

On June 27, 2025 (the “Initial Closing Date”), we entered into a Credit Agreement with Western Alliance Bank (the “Credit Agreement”) for a delayed draw term loan (the “Term Loan Facility”) and a revolving credit facility (the “Revolving Credit Facility”, and together with the Term Loan Facility, the “Nonconvertible Debt”). The Revolving Credit Facility had an initial funding commitment of up to $65.0 million which included (i) an initial commitment of $45.0 million and (ii) a $20.0 million uncommitted option, subject to syndication at terms acceptable to prospective lenders (with such increase implemented through the amendment executed on September 11, 2025). The Term Loan Facility had a commitment of $30.0 million which includes (i) an $18.0 million available on the Initial Closing Date and (ii) a $12.0 million available upon achieving certain milestones and lender approval (which were achieved upon the completion of the IPO). On the Initial Closing Date, we borrowed $22.0 million under the Revolving Credit Facility to repay all outstanding amounts under its previously existing debt facilities.

On September 11, 2025, the Credit Agreement was amended to, among other things, increase the Revolving Credit Facility funding commitment to up to $65.0 million. This increase reflects our lender’s commitment to fund the previously uncommitted $20.0 million option.

32


 

In February 2026, following completion of the IPO, we used a portion of the proceeds to repay all outstanding amounts under the Nonconvertible Debt. As of September 30, 2026, we have no outstanding debt under the Nonconvertible Debt.

Interest on borrowings under the Term Loan Facility is calculated at a rate equal to (i) 2.50% plus the highest of (w) the prime rate (as determined by reference to the Wall Street Journal), (x) the federal funds rate plus 0.50% per annum and (y) one month Term SOFR plus 1.00% per annum or (ii) one month Term SOFR plus 3.50% per annum, subject to a 2.00% Term SOFR floor. Interest-only payments are required to be made until July 10, 2027, then (i) with respect to $18.0 million of the Term Loan Facility, equal payments of outstanding principal and (ii) with respect to $12.0 million of the Term Loan Facility, 24 months after the borrowing of such amount with equal payments of outstanding principal, plus monthly interest payments, through the maturity date. As of September 30, 2026, there were no amounts outstanding under the Term Loan Facility. As of September 30, 2026, the maximum remaining capacity under the Term Loan Facility was $30.0 million.

Interest on borrowings under the Revolving Credit Facility is calculated at a rate equal to (i) 2.25% plus the highest of (w) the prime rate (as determined by reference to the Wall Street Journal), (x) the federal funds rate plus 0.50% per annum and (y) one month Term SOFR plus 1.00% per annum, or (ii) one month Term SOFR plus 3.25% per annum, subject to a 2.00% Term SOFR floor. Interest-only payments are required with a balloon principal payment on the maturity date. The interest rate applicable to borrowings under the Revolving Credit Facility was 7.0% as of December 31, 2025. As of September 30, 2026, there were no amounts outstanding under the Revolving Credit Facility.

The borrowing base for the Revolving Credit Facility requires us to maintain collateral in the form of accounts receivable and inventory. Amounts available to us are determined as the lower of (a) the current maximum capacity and (b) the sum of (i) 80% of our gross accounts receivable and (ii) 85% of the liquidation value of inventory, each subject to certain adjustments. The Nonconvertible Debt includes financial and nonfinancial covenant provisions. As of September 30, 2026, we were in compliance with all covenants related to the Nonconvertible Debt. As of September 30, 2026, the maximum remaining capacity under the Revolving Credit Facility was $65.0 million, with $58.2 million available for borrowing based on existing inventory and accounts receivable balances as described by the Credit Agreement.

Cash Flows

The following table summarizes our cash flows for the periods indicated:

 

 

Nine Months Ended September 30,

 

 

2026

 

 

2025

 

 

(dollars in thousands)

 

Net cash used in operating activities

 

$

(4,600

)

 

$

(23,236

)

Net cash used in investing activities

 

 

(3,438

)

 

 

(3,539

)

Net cash provided by financing activities

 

 

103,586

 

 

 

16,881

 

Net change in cash and cash equivalents

 

$

95,548

 

 

$

(9,894

)

Operating Activities

Net cash used in operating activities of $4.6 million for the nine months ended September 30, 2026 was primarily driven by net loss of $24.6 million, non-cash adjustments of $15.9 million, and a net increase in cash related to changes in operating assets and liabilities of $4.1 million. Non-cash adjustments primarily consisted of stock-based compensation of $9.8 million, inventory adjustments of $4.4 million, and depreciation and amortization expense of $1.7 million. Changes in cash flows related to operating assets and liabilities primarily consisted of a $9.1 million increase in accounts receivable driven by growth in our net sales, a $3.0 million increase in inventory to support the increase in sales volume, and a $2.6 million increase in prepaid expenses and other assets, primarily due to increases in prepaid insurance and other receivables. These uses of cash were partially offset by a $18.8 million

33


 

increase in accounts payable and accrued expenses and other current liabilities, primarily related to third-party manufacturing fees and raw material purchases to support growth in sales volume.

Net cash used in operating activities of $23.2 million for the nine months ended September 30, 2025 was primarily driven by net loss of $39.8 million, non-cash adjustments of $34.1 million and a net decrease in cash related to changes in operating assets and liabilities of $17.5 million. Non-cash adjustments primarily consisted of a change in fair value of derivative liability of $26.3 million, stock-based compensation of $2.9 million, a change in fair value of convertible preferred stock warrant liability of $1.4 million, depreciation and amortization expense of $0.9 million, inventory adjustments of $1.8 million, amortization of debt discounts and deferred financing costs of $0.5 million, non-cash interest expense of $0.2 million, and a change in fair value of SARs liability of $0.1 million. Changes in cash flows related to operating assets and liabilities primarily consisted of an $19.6 million increase in inventory to support the increase in sales volume, a $12.1 million increase in accounts receivable due to growth in our net sales, and a $0.4 million increase in prepaid expenses and other assets, primarily due to increases in prepaid insurance and deferred taxes. These uses of cash were partially offset by a $14.6 million increase in accounts payable and accrued expenses and other current liabilities primarily related to increased third-party manufacturing fees, accrued trade spend, and accrued marketing costs to support the growth in sales volume.

Investing Activities

For the nine months ended September 30, 2026 and 2025, net cash used in investing activities was $3.4 million and $3.5 million, related to purchases of property and equipment used in ongoing operations.

Financing Activities

For the nine months ended September 30, 2026, net cash provided by financing activities was $103.6 million, primarily consisting of $145.8 million of proceeds from our IPO, net of underwriting discounts and offering costs paid during the period and $0.8 million in proceeds from the exercise of stock options. This source of cash was partially offset by the repayment of our outstanding borrowings under our Credit Agreement of $43.0 million.

For the nine months ended September 30, 2025, net cash provided by financing activities was $16.9 million, primarily consisting of $21.0 million in borrowings from our credit facilities and $1.4 million in proceeds from the exercise of stock options. These sources of cash were partially offset by payments of deferred offering costs of $5.1 million and payments of debt issuance costs of $0.4 million.

Non-GAAP Financial Measures

To supplement our financial statements prepared and presented in accordance with GAAP, we use the non-GAAP financial measures Contribution Margin and Adjusted EBITDA to provide investors with additional information about our financial performance and to enhance the overall understanding of our past performance and future prospects. We are presenting these non-GAAP financial measures because we believe they provide an additional tool for investors to use in comparing our core financial performance over multiple periods with the performance of other companies.

However, non-GAAP financial measures have limitations in their usefulness to investors because they have no standardized meaning prescribed by GAAP and are not prepared under any comprehensive set of accounting rules or principles. In addition, non-GAAP financial measures may be calculated differently from, and therefore may not be directly comparable to, similarly titled measures used by other companies. As a result, non-GAAP financial measures should be viewed as supplementing, and not as an alternative or substitute for, our financial statements prepared and presented in accordance with GAAP.

To address these limitations, we provide a reconciliation of Contribution Profit to gross profit and Adjusted EBITDA to net loss. We encourage investors and others to review our financial information in its entirety, not to rely on any single financial measure, and to view Contribution Margin and Adjusted EBITDA in conjunction with their respective related GAAP financial measures.

34


 

Contribution Margin

We use Contribution Margin, which we define as Contribution Profit divided by net sales, to measure our financial and operating performance (“Contribution Margin”). To derive Contribution Profit, we subtract from gross profit our outbound freight costs associated with shipping goods to customers included in selling, general and administrative expenses (“Contribution Profit”).

We use Contribution Margin as part of our overall assessment of performance, including the preparation of our annual operating budget and quarterly forecasts, to evaluate the effectiveness of our business strategies, and to communicate with our board of directors (“Board of Directors") concerning our financial performance. We believe Contribution Margin is useful to investors for year-to-year comparisons of our business and in evaluating and understanding our operating results and ability to scale. Contribution Margin is also useful to investors because our management uses Contribution Margin, in conjunction with financial measures prepared in accordance with GAAP, to evaluate our operating results and financial performance.

Contribution Margin decreased by 5% for the three months ended September 30, 2026 compared to the three months ended September 30, 2025, and by 2% for the nine months ended September 30, 2026, compared to the nine months ended September 30, 2025. These decreases were primarily driven by the aforementioned factors mentioned in the discussion of gross profit in the results of operations above. These decreases were partially offset by increased order sizes and increased customer pickups, which reduced freight costs per case and positively impacted Contribution Margin.

The following table provides a calculation of Contribution Margin:

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

2026

 

 

2025

 

 

2026

 

 

2025

 

(dollars in thousands)

 

Net sales

$

89,067

 

 

$

66,036

 

 

$

247,179

 

 

$

176,656

 

Cost of goods sold

 

56,915

 

 

 

38,251

 

 

 

154,700

 

 

 

105,325

 

Gross profit

 

32,152

 

 

 

27,785

 

 

 

92,479

 

 

 

71,331

 

Less: Outbound freight

 

(4,009

)

 

 

(3,369

)

 

 

(11,362

)

 

 

(9,851

)

Contribution Profit

$

28,143

 

 

$

24,416

 

 

$

81,117

 

 

$

61,480

 

Gross margin

 

36

%

 

 

42

%

 

 

37

%

 

 

40

%

Contribution Margin

 

32

%

 

 

37

%

 

 

33

%

 

 

35

%

 

Adjusted EBITDA

We report our financial results in accordance with GAAP. However, management believes that Adjusted EBITDA, a non-GAAP financial measure, provides investors with additional useful information in evaluating our performance.

We calculate Adjusted EBITDA as net loss, adjusted to exclude: (1) change in fair value of derivative liability; (2) change in fair value of convertible preferred stock warrant liability; (3) change in fair value of stock appreciation rights ("SARs") liability; (4) stock-based compensation, including expense related to the acceleration of certain awards in connection with our IPO; (5) payroll taxes related to stock-based compensation; (6) depreciation and amortization; (7) amortization and acceleration of certain payments under the Spokesperson Agreement (as defined in Note 12, Related-Party Transactions in Part I, Item 1. of this Quarterly Report on Form 10-Q) for services received in connection with our IPO; (8) one-time bonuses related to our IPO; (9) interest expense; (10) interest income; and (11) provision for income taxes.

In the third quarter of 2026, we revised our definition of Adjusted EBITDA to exclude payroll tax expense related to stock-based compensation, which is comprised of employer taxes incurred upon (i) vesting of restricted stock units ("RSUs") and (ii) exercise of nonqualified stock options. The amount of payroll tax expense related to employee stock transactions is dependent on RSU settlements, option exercises, related stock price, and other factors that are beyond our control and that do not correlate to the operation of our business. The RSUs were granted

35


 

in the first quarter of 2026 and the first tranche vested upon the expiration of the lockup period on August 5, 2026, at which point these amounts became significant. Because such amounts were not significant in prior periods, prior period disclosures were not recast.

We also revised our definition of Adjusted EBITDA to exclude the change in fair value of our SARs liability. The change in fair value is driven by the change in our stock price and other factors that are beyond our control and that do not correlate to the operations of our business. These SARs were granted in the first quarter of 2025. Because the change in fair value of our SARs liability was not significant in prior periods, prior period disclosures were not recast.

Adjusted EBITDA is a financial measure that is not required by, or presented in accordance with, GAAP. We believe that Adjusted EBITDA, when taken together with our financial results presented in accordance with GAAP, provides meaningful supplemental information regarding our operating performance and facilitates internal comparisons of our historical operating performance on a more consistent basis by excluding certain items that may not be indicative of our business, results of operations, or outlook. In particular, we believe that the use of Adjusted EBITDA is helpful to our investors as it is a measure used by management in assessing the health of our business, determining incentive compensation, and evaluating our operating performance, as well as for internal planning and forecasting purposes.

Adjusted EBITDA is presented for supplemental informational purposes only, has limitations as an analytical tool, and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. Some of the limitations of Adjusted EBITDA include that (1) it does not properly reflect capital commitments to be paid in the future, (2) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and Adjusted EBITDA does not reflect these capital expenditures, (3) it does not consider the impact of stock-based compensation and payroll taxes related to stock-based compensation, (4) it does not reflect other non-operating expenses, including interest expense, (5) it does not consider the impact of any derivative liability valuation adjustments, (6) it does not reflect tax payments that may represent a reduction in cash available to us, and (7) it does not consider amortization of payments under the Spokesperson Agreement for services received in connection with our IPO. In addition, our use of Adjusted EBITDA may not be comparable to similarly titled measures of other companies because they may not calculate Adjusted EBITDA in the same manner, limiting its usefulness as a comparative measure. Because of these limitations, when evaluating our performance, you should consider Adjusted EBITDA alongside other financial measures, including our net income and other results stated in accordance with GAAP.

36


 

The following table presents a reconciliation of Adjusted EBITDA to net (loss) income, the most directly comparable financial measure stated in accordance with GAAP, for the periods presented:

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

2026

 

 

2025

 

 

2026

 

 

2025

 

(dollars in thousands)

 

Net loss

$

(3,813

)

 

$

(11,255

)

 

$

(24,574

)

 

$

(39,759

)

Change in fair value of derivative liability (1)

 

—

 

 

 

8,460

 

 

 

(340

)

 

 

26,320

 

Change in fair value of convertible preferred
   stock warrant liability
 (1)

 

—

 

 

 

437

 

 

 

(13

)

 

 

1,365

 

Change in fair value of SARs liability

 

(74

)

 

 

—

 

 

 

(2

)

 

 

—

 

Stock-based compensation

 

2,995

 

 

 

997

 

 

 

11,968

 

 

 

2,895

 

Payroll taxes related to stock-based compensation

 

86

 

 

 

—

 

 

 

86

 

 

 

—

 

Depreciation and amortization

 

608

 

 

 

353

 

 

 

1,657

 

 

 

907

 

Amortization and acceleration of
   Spokesperson Agreement expense for
   services received in connection to the IPO

 

—

 

 

 

649

 

 

 

5,405

 

 

 

1,947

 

IPO transaction bonus

 

—

 

 

 

—

 

 

 

1,699

 

 

 

—

 

Interest expense

 

50

 

 

 

801

 

 

 

519

 

 

 

1,984

 

Interest income

 

(866

)

 

 

(59

)

 

 

(2,200

)

 

 

(253

)

Provision for income tax

 

27

 

 

 

539

 

 

 

69

 

 

 

42

 

Adjusted EBITDA

$

(987

)

 

$

922

 

 

$

(5,726

)

 

$

(4,552

)

 

(1)
Amount reflects the change in fair value of derivative liability related to Convertible Notes and change in fair value of convertible preferred warrant liability related to our Nonconvertible Debt.

Critical Accounting Estimates

The preparation of our financial statements in conformity with GAAP requires us to make estimates and judgments that affect the amounts reported in the financial statements and related notes thereto. Critical accounting estimates are those estimates that, in accordance with GAAP, involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on our financial statements. Management has determined that our most critical accounting estimates are those relating to revenue recognition, valuation of derivative liability, fair value of common stock and stock-based compensation. Although we believe that the estimates we use are reasonable, due to the inherent uncertainty involved in making these estimates, actual results reported in future periods could differ materially from those estimates. The following is a summary of certain accounting estimates we consider critical. For further discussion about our accounting policies, see Note 2 “Summary of Significant Accounting Policies” to our financial statements in Part I, Item 1. in this Quarterly Report on Form 10-Q.

Revenue Recognition

Our revenue is generated through sales of Pouches, snacks and other products for babies and kids through retail channels, which include traditional brick-and-mortar stores and e-commerce platforms, as well as directly to consumers through our DTC platform that we operate. We recognize revenue when control of the products transfers to the customer, which occurs upon customer pickup or delivery of the products to the customer for retail sales or when the product is delivered to the carrier for DTC sales. Our revenue is recognized net of allowances for sales discounts and promotions and any taxes collected from consumers.

We offer sales discounts and promotions to our customers through various programs. These programs include sales incentives, trade allowances, slotting fees, including baby cooler slotting fees, coupon offers, rebates and term discounts. The costs of these sales discounts and promotions are accounted for as reductions in the transaction price. We estimate variable consideration related to the cost of sales discounts and promotions during the period the product is sold. We recognize an allowance for estimated trade discounts. We also recognize an accrual for the estimated sales discounts and promotional activities that have been incurred but not settled as of each balance sheet

37


 

date. Our estimate of trade discounts and accrued promotional activities is a management estimate based on the terms and timing of our programs offered, expected participation based on our historical experience with similar programs and forecasted sales volumes.

We do not believe it is reasonably likely that there will be a material change in the estimates or assumptions used to recognize revenue. Estimates are made based on historical experience and other factors. Typically, programs that are offered have a short duration and historical differences between actual experience compared to estimated volumes, performance and redemptions have not been significant to the annual financial statements. However, if the level of redemption rates, volumes or performance were to vary significantly from our estimates, we may be exposed to gains or losses that could be material.

Derivative Liability

Our Convertible Notes contain conversion features that meet the definition of an embedded derivative that requires bifurcation from the Convertible Notes and measurement at fair value. The derivative liability is initially measured at fair value on issuance and is subject to remeasurement at each reporting period with changes in fair value recognized in change in fair value of derivative liability in the statements of operations and comprehensive loss.

We determine the fair value of our derivative liability related to Convertible Notes using a “with-and-without” methodology. This involves valuing the instrument with and without the embedded derivative, with the difference representing the derivative liability’s fair value at issuance. Key assumptions include the estimated fair value of the underlying preferred stock, the probability and timing of conversion events, dividend yields, volatility, discount rate, risk-free rate and remaining expected life. Changes in these inputs can materially impact the fair value and reported financial results, including loss and comprehensive loss for the applicable reporting period.

Fair Value of Common Stock

Prior to our initial public offering in February 2026 the fair value of the common stock underlying our stock-based awards was determined by management with the assistance of third-party valuation specialists using a hybrid approach. Under the hybrid approach, a probability weighting was assigned to both a merger and acquisition (“M&A”) scenario and an initial public offering scenario. For the M&A scenario, management uses the Income Approach and Guideline Public Company (“GPC”) approach to determine the estimated fair value of equity, which was then allocated to the various classes of equity using the Option Pricing Method (“OPM”). Under the OPM, the shares were valued by creating a series of call options with exercise prices based on the liquidation preferences and conversion terms of each equity class. The estimated fair values of the common stock, preferred stock and preferred stock warrants are then inferred by analyzing these options. For the initial public offering scenario, we estimated the exit value upon an initial public offering and then performed a waterfall analysis to systematically allocate the equity value across share classes according to their fully diluted ownership positions.

For the income approach, we use a discounted cash flow analysis and the significant assumptions used in determining the estimated fair value of our common stock under the income approach primarily relate to the selection of the revenue growth rate, the forecasted EBITDA margin, and the selected discount rate used to discount the future cash flows. Under the GPC approach, the selection of revenue and EBITDA multiples requires significant judgment. Under the initial public offering scenario there is significant judgment used in determining the exit value upon the completion of a successful initial public offering. There is also significant judgment in weighting the probability of the M&A scenario versus the initial public offering scenario.

Subsequent to the completion of our IPO in February 2026, our Board of Directors determines the fair value of our common stock based on the closing price of our common stock as reported on the date of grant on the primary stock exchange on which our common stock is listed.

38


 

Stock-Based Compensation

We recognize stock-based compensation related to equity classified awards based on the grant-date fair value of the awards. For awards that vest based only on continued service, we recognize stock-based compensation cost on a straight-line basis over the requisite service period, which is generally the vesting period of the awards. For stock options with performance vesting conditions, we recognize stock-based compensation using an accelerated attribution method when it is probable the performance condition will be achieved. The grant date fair value of stock options that contain service or performance conditions is estimated using the Black-Scholes option-pricing model. The grant date fair value of restricted stock awards that contain service vesting conditions is estimated based on the fair value of the underlying shares on grant date.

The fair value of liability classified awards such as stock appreciation rights awards, is determined using the Black-Scholes option-pricing model on the date of grant and is remeasured each reporting period through the date of settlement. Our liability classified stock appreciation rights are subject to both service and performance conditions. The performance condition, which includes either an initial public offering or a change in control event, is not considered achievable for accounting purposes until it happens. As a result, we will not recognize any compensation for these awards until it is probable that the performance condition will be met.

Determining the fair value of stock-based awards requires judgment. The Black-Scholes option-pricing model is used to estimate the fair value of stock options that have service and/or performance vesting conditions. The assumptions used in these option-pricing models require the input of subjective assumptions and are as follows:

•
Fair value—Please refer to the section titled “Fair value of Common Stock” above for the valuation methodology of our common stock.
•
Expected volatility—Expected volatility is based on historical volatilities of a publicly traded peer group based on daily price observations over a period equivalent to the expected term of the awards.
•
Expected term—For stock options with only service vesting conditions, the expected term is determined using the simplified method, which estimates the expected term using the contractual life of the option and the vesting period.
•
Risk-free interest rate—The risk-free interest rate is based on the U.S. Treasury yield of treasury bonds with a maturity that approximates the expected term of the awards.
•
Expected dividend yield—The dividend yield is based on our current expectations of dividend payouts. We currently have no history or expectation of paying cash dividends on our common stock.

The determination of stock-based compensation cost is inherently uncertain and subjective and involves the application of valuation models and assumptions requiring the use of judgment. If factors change and different assumptions are used, stock-based compensation and net losses could be significantly different.

We will continue to use judgment in evaluating the expected volatility and expected terms utilized in our stock-based compensation calculations on a prospective basis. As we continue to accumulate additional data related to our common stock, we may refine our estimates, which could materially impact our future stock-based compensation. See Note 11 to our unaudited condensed consolidated financial statements in Part I, Item 1. in this Quarterly Report on Form 10-Q for information concerning certain of the specific assumptions we used in applying the Black-Scholes option pricing model to determine the estimated fair value of our stock options granted in the three and nine months ended September 30, 2026 and 2025.

During the three months ended September 30, 2026 and 2025, we recorded $3.0 million and $1.0 million in stock-based compensation. There was $0.1 million and an insignificant reduction in net sales associated with stock appreciation rights issued to a customer and no reduction in net sales associated with warrants issued to a customer during the three months ended September 30, 2026 and 2025.

During the nine months ended September 30, 2026 and 2025, we recorded $12.0 million and $2.9 million in stock-based compensation. There was $0.2 million and $0.1 million reduction in net sales associated with stock

39


 

appreciation rights issued to a customer and no reduction in net sales associated with warrants issued to customers as no warrants to customers were issued during the nine months ended September 30, 2026 and 2025.

As of September 30, 2026, there was $10.1 million in unrecognized compensation related to unvested service-based vesting options which is expected to be recognized over a weighted-average period of 2.8 years.

As of September 30, 2026, there was $7.3 million in unrecognized compensation related to unvested RSUs which is expected to be recognized over a weighted-average period of 2.4 years.

Recent Accounting Pronouncements

See the sections titled “Summary of Significant Accounting Policies—Recently Adopted Accounting Pronouncements” and “—Recent Accounting Pronouncements Not Yet Adopted” in Note 2 to our unaudited condensed consolidated financial statements in Part I, Item 1. in this Quarterly Report on Form 10-Q for additional details.

Emerging Growth Company Status

We are an emerging growth company, as defined in the JOBS Act. Section 107 of the JOBS Act provides that an “emerging growth company” may take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act of 1933 (“Securities Act”) for complying with new or revised accounting standards. Therefore, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to use the extended transition period under the JOBS Act. Accordingly, our financial statements may not be comparable to the financial statements of public companies that comply with such new or revised accounting standards.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily the result of fluctuations in raw material prices, energy, fuel costs, interest rates, and inflation.

Raw Materials Pricing Risk

Our profitability is dependent on, among other things, our ability to anticipate and react to commodity and packaging costs. The prices and availability of ingredients we use in the process of manufacturing our products are subject to many factors beyond our control, such as the number, size and production levels of farms that provide ingredients, the vagaries of these farming businesses, including poor harvests due to adverse weather conditions, natural disasters and pestilence and changes in national and world economic conditions.

In addition, we purchase some ingredients and other materials offshore. The price and availability of such ingredients and materials is affected by political events, labor shortages, transportation and logistics disruptions or other conditions in these countries or tariffs or trade wars. New or increased tariffs or resultant trade wars, as well as labor shortages or disruptions in transportation and logistics networks, could have an adverse effect on us or on our suppliers, distributors or customers, which could lead to significant increases in the costs of materials and services, resulting in product cost increases and reduced consumer demand.

A hypothetical 10% increase or decrease in the weighted-average cost of these commodities and raw materials would have resulted in an increase or decrease to cost of goods sold of approximately $2.0 million and $5.4 million for the three and nine months ended September 30, 2026. We seek to mitigate the impact of raw materials cost increases by negotiating pricing agreements and by a combination of cost savings initiatives and efficiencies and price increases to our customers.

40


 

Interest Rate Risk

We are subject to interest rate risk on amounts drawn under our Nonconvertible Debt, which incurs interest at variable rates. See Part I, Item 2. “Management’s Discussion of Results of Operation and Financial Condition —Liquidity and Capital Resources—Nonconvertible Debt.” Following completion of the IPO in February 2026, we used a portion of the proceeds therefrom to repay all outstanding amounts under the Nonconvertible Debt.

Our interest-earning instruments, including cash held in on demand interest-bearing accounts, also carry a degree of interest rate risk.

We do not believe that a hypothetical 100 basis points change in interest rates would have a material effect on our results of operations or financial condition.

We do not enter into investments for trading or speculative purposes and have not used any derivative financial instruments to manage our interest rate risk exposure.

Inflation Risk

Inflation generally affects us by increasing our cost of labor, logistics, commodities, packaging and manufacturing costs, as well as fuel and energy costs. We do not believe that inflation has had a material effect on our business, results of operations or financial condition. If our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could harm our business, results of operations and financial condition.

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

As required by Rule 13a-15(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), under the supervision and with the participation of Company management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our CEO and CFO concluded that, as of September 30, 2026, our disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

41


 

PART II—OTHER INFORMATION

For information regarding our legal proceedings, refer to Note 6 of our Financial Statements in Part I, Item 1 of this Quarterly Report on Form 10-Q.

Item 1A. Risk Factors.

For a discussion of our potential risks and uncertainties, see the information under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on March 16, 2026, and our Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 filed with the SEC on May 7, 2026 (the “Quarterly Report”). Except as set forth below, there have been no material changes to the risk factors disclosed in our Annual Report or the Quarterly Report.

Risks Relating to Our Business and Industry

If our products are contaminated, alleged to be contaminated or are rumored to have adverse effects, or if our products are alleged to cause illness or injury, be mislabeled, or misbranded or fail to comply with governmental regulations, we may suffer adverse public relations, need to recall our products and experience product liability claims.

The sale of food products involves the risk of illness or injury to consumers. Such illness and injury may result from inadvertent mislabeling, tampering by unauthorized third parties, product contamination, food-borne illnesses, allergens, or spoilage. We believe our consumers rely on us to provide them with high-quality natural and organic food products. Concerns regarding the ingredients used in our products, the safety or quality of our products, or our supply chain may cause consumers to stop purchasing our products, even if the basis for the concern is unfounded, has been addressed, or is outside of our control. There can be no assurance that our products, many of which contain ingredients that we buy from third-party suppliers, will always comply with the standards set for our products. For example, genetically modified organisms may contaminate our products (including through cross-pollination) and not be easily detected, a potential issue that may be exacerbated if we are unable to trace the affected raw materials to their supplier lots. While we are subject to governmental inspection and regulations and believe our facilities and those of our co-manufacturers and suppliers, including co-packers, comply in all material respects with all applicable laws and regulations, if ingredients or materials used for our products are alleged or proved to include contaminants that affect the safety or quality of our products or are otherwise rumored to have adverse effects, for any reason, we may need to find alternate ingredients or materials for our products, delay production of our products, or discard or otherwise dispose of our products, which could adversely affect our results of operations.

We have in the past been, are currently, and may in the future be exposed to product recalls, including voluntary recalls, product withdrawals and reformulations, and adverse public relations if our products are alleged to cause illness or injury or if we are alleged to have mislabeled or misbranded our products or otherwise violated governmental regulations. We have voluntarily recalled and may also in the future voluntarily recall or withdraw products that we consider below our standards, whether for taste, appearance or otherwise, in order to protect our brand’s reputation. Product recalls or withdrawals can result in substantial and unexpected expenditures, destruction of product inventory, and lost sales due to the unavailability of the product for a period of time, which could reduce profitability and cash flow. In October 2026, we initiated a voluntary recall and reformulation of our Tractor Wheels soft-baked bars. In connection with this recall, we are assessing product, customer and recall-related costs, lost sales and potential insurance recoveries, and we cannot yet reliably estimate the total costs we expect to incur or the amount or timing of any recovery.

In addition, a product recall or withdrawal may require significant management attention, operational resources and communications with consumers, regulators, retailers and distributors. As an example, in June 2024, we initiated a voluntary recall of a single product due to potential Listeria contamination, which we discovered after conducting routine finished product testing. See Part I, Item 1. “Business—Our Product Quality and Safety.” Although we received no reports of harm to customers as a result of this potential contamination, this recall resulted in diversion

42


 

of management time to identify and remediate the issue. We anticipate that the October 2026 recall of Tractor Wheels will similarly divert management’s attention and require significant operational resources to address.

Product recalls, product liability claims (even if unmerited or unsuccessful), or any other events that cause consumers to no longer associate our brand with high-quality may also result in adverse publicity or legal challenges, harm our reputation and hurt the value of our brand, lead to a decline in consumer confidence in and demand for our products, lead to increased scrutiny, fines, or other penalties by federal and state regulatory agencies of our operations, and could result in further volatility in the market price of our common stock, which could have a material adverse effect on our business, financial condition, and results of operations. For example, despite our rigorous testing for heavy metals (e.g., arsenic, cadmium, lead, and mercury), and our robust programs to ensure compliance with food safety laws and regulations, such as Assembly Bill 899 in California, we may fail to adequately detect such toxins before our products reach the shelf, which could subject our products to a recall, and may negatively impact consumer perception of our products and our reputation.

We also may be subject to product liability claims and adverse public relations if consumption or use of our products is alleged to cause injury or illness, and our insurance may not be adequate to cover all liabilities we may incur in connection with product liability claims. For example, punitive damages are generally not covered by insurance. In addition, we may not be able to continue to maintain our existing insurance, obtain comparable insurance at a reasonable cost, if at all, or secure additional coverage (which may result in future product liability claims being uninsured). A product liability judgment against us or an agreement to settle a product liability claim could also result in substantial and unexpected expenditures, which would reduce profitability and cash flow. In addition, even if product liability claims against us are not successful or are not fully pursued, these claims could harm our brand’s image, be costly and time-consuming and may require management to spend time defending the claims rather than operating our business. From time to time, we have and may continue to be subject to claims from competitors or consumers, including consumer class actions, alleging that our product claims are deceptive, such as products being mislabeled or misbranded. For example, we have had legal claims brought against us in California for our use of the phrases “4g Plant Protein,” “Omega-3’s,” and “Excellent Source of Choline” in describing certain of our products. These claims were ultimately resolved and settled for an immaterial amount. In addition, we have been named in a putative nationwide class action lawsuit by plaintiffs alleging that our Wild Rumpus Avocado pouch (which is a blend of organic pineapple, banana, apple, avocado and mint) should be described solely as a “Fruit Blend” rather than a “Fruit & Veggie Blend.” Regardless of their merit, these types of claims can require significant time and expense to investigate and defend. Whether or not a false marketing claim is successful, such assertions could have an adverse effect on our business, financial condition, and results of operations, and the negative publicity surrounding them could harm our reputation and brand.

Adverse publicity about the quality or safety of our products, whether or not ultimately based on fact, may discourage consumers from buying our products and have an adverse effect on our brand, reputation, and operating results, particularly if our products are perceived as posing illness or risk of injury to children. We have no control over our products once purchased by consumers. Accordingly, consumers may fail to refrigerate our products or store our products for long periods of time, which may adversely affect the quality of our products. If consumers do not perceive our products to be of high-quality, our reputation and the value of our brand could be diminished, and our business, financial condition, and results of operations would be adversely affected. Any loss of confidence on the part of consumers in the ingredients used in our products or in the safety and quality of our products would be difficult and costly to overcome. Further, the growing use of social and digital media by us, our consumers, and third parties increases the speed and extent that information or misinformation and opinions can be shared. Negative publicity about us, our brand, or our products on social or digital media could seriously damage our brand and reputation. If we do not maintain a favorable perception of our brand, our business, reputation, financial condition, and results of operations could be adversely affected. Any such adverse effect on our business, reputation, results of operations, or financial condition could be exacerbated by our position in the market as a socially conscious, Clean Label Project-certified purveyor of high-quality natural and organic food products and may significantly reduce our brand value.

43


 

Risks Relating to Litigation and Regulation

We are subject to significant governmental regulation and failure to comply with such regulations may have a material adverse effect on our business, financial condition, and results of operations.

Our business is highly regulated at the federal, state, and local levels, and our products and distribution operations require various licenses, permits, and approvals. Given the nature of our business, the laws and regulations that we are required to comply with are constantly evolving and placing additional restrictions on the way we operate our business and produce our products. The products that we distribute in the United States are subject to inspection by the USDA. Our warehouse and distribution centers are subject to inspection by the USDA, the United States Department of Labor Occupational and Health Administration, the Environmental Protection Agency, and various state health and workplace safety authorities. Our United States transportation operations are subject to regulation by the United States Department of Transportation and the United States Federal Highway Administration. In addition, the various federal, state, and local laws, regulations, and administrative practices to which we are subject require us to comply with numerous provisions regulating areas such as environmental, health and sanitation standards, food safety, marketing of natural or organically produced food, facilities, pharmacies, equal employment opportunity, public accessibility, employee benefits, wages and hours worked, and licensing for the sale of food, among others. For example:

Environmental, Health and Safety: Our operations are subject to extensive and increasingly stringent laws and regulations pertaining to the protection of the environment, including those relating to the discharge of materials into the environment, the disposal of food by-products, the handling, treatment, and disposal of wastes, maintenance of refrigeration systems, and remediation of soil and groundwater contamination. Compliance with existing or changing environmental and safety requirements, including more stringent limitations imposed or expected to be imposed in any recently renewed or soon-to-be renewed environmental permits, may require capital expenditures. Additionally, concern over climate change, including the impact of global warming, has led to significant United States and international legislative and regulatory efforts to limit greenhouse gas emissions. Increased regulation regarding greenhouse gas emissions, particularly with respect to diesel engine emissions, could result in substantial additional operating expenses. These expenses may include an increase in the cost of the fuel and other energy we purchase, and capital costs associated with updating or replacing our vehicles sooner than planned. Until the timing, scope and extent of such regulation becomes known, we cannot predict its effect on our results of operations. It is reasonably possible, however, that it could result in material costs, which we may be unable to pass on to our customers. Further, our business may be subject to climate-related transition risks, which arise from society’s transition toward a low-carbon economy due to changes in laws or regulations, technological advancements, and investor and consumer sentiment.

While many of our initiatives will create efficiencies and return on investment, the transition to a low-carbon economy generally and our own efforts to reduce emissions could lead to increased costs to transition to or invest in renewable energy sources, including electric vehicles, increased compliance costs, including tracking and reporting systems, and increased costs of products, commodities, and energy. Further, if our tracking and reporting systems are incomplete or inaccurate, or if we fail to achieve progress with respect to our goals on a timely basis, or at all, our reputation, business, financial condition, and results of operations could be adversely impacted.

Food Safety and Marketing: There is significant governmental scrutiny, regulations, and public awareness regarding food quality and food and drug safety. We may be adversely affected if consumers lose confidence in the safety and quality of the food we manufacture or the food and drug products we distribute. In addition, we are subject to governmental scrutiny of and public awareness regarding food safety and the sale, packaging, and marketing of natural and organic products. Compliance with these laws may impose a significant burden on our operations. As a baby food company, we are also subject to Assembly Bill 899 in California, which requires manufacturers of baby food to (i) test and disclose the levels of four toxic elements (arsenic, cadmium, lead, and mercury) that may be present in baby food and (ii) meet particular labeling requirements. In addition, “Proposition 65, the Safe Drinking Water and Toxic Enforcement Act of 1986,” in California exposes all food companies to the possibility of having to provide warnings on their products in that state. If we were required to add warning labels to any of our products or place warnings in locations where our products are sold in order to comply with Proposition 65, the sales of those products and other products of our Company could suffer, not only in those locations but elsewhere. Additionally, in 2022, California enacted the Plastic Pollution Prevention and Packaging Producer Responsibility

44


 

Act, which, among other things, requires a 25% reduction of plastics in single-use products in the state by 2032 and escalates recycling, reuse, and composting rates for single-use packaging, regardless of material, used in the state over time. Numerous other U.S. municipalities and states and certain other countries, including Canada, have also proposed or enacted legislation prohibiting or restricting the sale and use of certain foodservice products and requiring them to be replaced with recyclable or compostable alternatives. Several provinces in Canada, as well as states in the United States, have enacted legislation imposing fees or other costs on manufacturers and other suppliers of single-use packaging and foodservice products to encourage and fund recycling of those products. Any such legislation, as well as voluntary initiatives similarly aimed at reducing the level of single-use packaging waste, could reduce demand for our products and/or increase the costs of producing our products.

Wage Rates and Paid Leave: Changes in federal, state, or local minimum wage and overtime laws or employee paid leave laws could cause us to incur additional wage costs, which could adversely affect our operating margins. Failure to comply with existing or new laws or regulations could result in significant damages, penalties and/or litigation costs.

Payment Card Transactions: As a merchant that accepts debit and credit cards for payment, we are subject to the Payment Card Industry Data Security Standard (“PCI DSS”), issued by the PCI Council. Additionally, we are subject to PCI DSS as a service provider, which is a business entity that is not a payment brand directly involved in the processing, storage, or transmission of cardholder data. PCI DSS contains compliance guidelines and standards with regard to our security surrounding the physical and electronic storage, processing, and transmission of individual cardholder data. By accepting debit cards for payment, we are also subject to compliance with American National Standards Institute data encryption standards and payment network security operating guidelines. The cost of complying with stricter privacy and information security laws, standards, and guidelines, including evolving PCI DSS standards, and developing, maintaining, and upgrading technology systems to address future advances in technology, could be significant and we could experience problems and interruptions associated with the implementation of new or upgraded systems and technology or with maintenance or adequate support of existing systems. Failure to comply with such laws, standards, and guidelines or payment card industry standards such as those involving MasterCard, Visa and Europay (EMV) transactions, could have a material adverse impact on our business, financial condition, or results of operations.

Foreign Operations: Our supplier base includes both domestic and foreign suppliers. In particular, we source many of the key ingredients that we use in our products from South and Central America and Mexico. In addition, we have customers located outside the United States. Accordingly, laws and regulations affecting the importation and taxation of goods, including duties, tariffs, and quotas or changes in the enforcement of those laws and regulations could adversely impact our financial condition and results of operations. In addition, we are required to comply with laws and regulations governing export controls, and ethical, anti-bribery, and similar business practices such as the Foreign Corrupt Practices Act.

Privacy and Related Laws: We are subject to a variety of federal, state, and foreign laws and industry standards that relate to data privacy, data security, and consumer marketing. The legal and regulatory framework for these topics is rapidly evolving and may require increased monitoring and compliance costs and result in increased legal and financial exposure if we fail to remain compliant, or are alleged to be noncompliant, with such laws.

AI Technologies: There are many evolving laws, regulations, and standards regarding the development and use of AI technologies. New laws, regulations, or industry standards governing AI use could require us to modify our practices regarding AI use, increase our operating costs, or restrict our ability to use certain AI technologies in our operations in order to remain compliant with such regulations or standards.

Climate Change: Changing rules, public disclosure regulations, and stakeholder expectations related to climate change have resulted in, and may continue to result in, increased management time and attention spent complying with or meeting such regulations and expectations.

 

The failure to comply or maintain compliance with applicable governmental laws and regulations, including those referred to above, could result in, among other things, administrative, civil, or criminal penalties or fines (including in connection with class action lawsuits); mandatory or voluntary product recalls, withdrawals, reformulations,

45


 

additional consumer notifications or other corrective actions; warning or other letters; cease and desist orders against operations that are not in compliance; closure of facilities or operations; the loss, revocation or modification of any existing licenses, permits, registrations or approvals; the failure to obtain additional licenses, permits, registrations, or approvals in new jurisdictions where we intend to do business; or the loss of our ability to participate in federal and state healthcare programs, any of which could make it more costly or challenging to manufacture and sell our products or otherwise have a material adverse effect on our business, financial condition, or results of operations. In addition, governmental units may make changes in the regulatory frameworks within which we operate that may require us to incur substantial increases in costs in order to comply with such laws and regulations.

Changes in existing laws or regulations, or the adoption of new laws or regulations, may increase our costs and otherwise adversely affect our business, financial condition, and results of operations.

The manufacture and marketing of food products is highly regulated. We, our farmer partners, our suppliers (including co-packers), and our co-manufacturers are subject to a variety of laws and regulations. These laws and regulations apply to many aspects of our business, including the manufacturing, packaging, labeling, distribution, advertising, sale, quality, and safety of our products, as well as the health and safety of our crew members and the protection of the environment. In the United States, we are subject to regulation by various government agencies, including the Food and Drug Administration (the “FDA”), the USDA, the Federal Trade Commission (the “FTC”), the Consumer Product Safety Commission, the Occupational Safety and Health Administration, and the Environmental Protection Agency, as well as various state and local agencies. We are also regulated outside the United States by various international regulatory bodies, including Health Canada. These regulatory agencies and bodies regularly propose rules and issue guidance, some of which are or may be relevant to our business. For example, on January 16, 2025, the FDA proposed a rule (90 Fed. Reg. 5426), which, if finalized, would require a front-of-package nutrition information box on most packaged foods to assist consumers in more easily identifying healthy foods. In addition to compliance costs associated with understanding the requirements and updating product labeling or reformulating our products, implementing this rule may negatively impact consumer perception of our products and our reputation, which could adversely affect our financial condition and results of operations. In addition, we are subject to certain standards, such as GFSI standards and review by voluntary organizations, such as the Council of Better Business Bureaus’ National Advertising Division. We could incur costs, including fines, penalties, and third-party claims, because of any violations of, or liabilities under, such requirements, including any competitor or consumer challenges relating to compliance with such requirements. For example, in connection with the marketing and advertisement of our products, we could be the target of claims relating to false or deceptive advertising, including under the auspices of the FTC and the consumer protection statutes of some states.

The regulatory environment in which we operate could change significantly and adversely in the future, particularly in light of the rapidly evolving focus on public health and food regulation by the U.S. presidential administration. For example, the U.S. presidential administration’s “Make America Healthy Again” movement may have a significant impact on the food regulatory landscape and may result in the implementation of certain food regulation changes that could be adverse to our business. Product recalls or withdrawals may also increase scrutiny of our product design, warnings, labeling, packaging, manufacturing processes, complaint handling and recall communications, which could increase our costs or delay our ability to resume shipments. If we fail to anticipate or adapt to new rules governing food manufacturing, labeling, or packaging, it may lead to an increase in costs or interruptions in production, either of which could adversely affect our operations and financial condition. Changes in marketing or labeling requirements or standards related to our products could require us to revise or discontinue making certain claims or utilizing certain branding elements, which may make our products less appealing to consumers. New or revised government laws and regulations could result in additional compliance costs and, in the event of non-compliance, civil remedies, including fines, injunctions, withdrawals, recalls or seizures, and confiscations, as well as potential criminal sanctions, any of which may adversely affect our business, financial condition, and results of operations.

 

 

46


 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Recent Sales of Unregistered Equity Securities

None.

Issuer Purchases of Equity Securities

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

Rule 10b5-1 Trading Plans

In accordance with the disclosure requirements set forth in Item 408(a) of Regulation S-K, the following table discloses any officer (as defined in Rule 16a-1(f) under the Exchange Act), director, or entity controlled by such officer or director who adopted or terminated a contract, instruction, or written plan for the sale of securities of the Company intended to satisfy the affirmative defense of Rule 10b5-1(c) during the quarterly period ended September 30, 2026:

Name

Title

Action Taken

Adoption Date

Start Date of Trading Arrangement

End Date of Trading Arrangement

Aggregate Number of Securities to be Sold

John Foraker(1)

Chief Executive Officer and Director

Adoption(1)

9/11/2026

12/11/2026

11/30/2027

Up to 150,000 shares of common stock

Cassandra Curtis

Director

Adoption

9/1/2026

12/1/2026

11/30/2027

Up to 323,543  shares of common stock

Walter Robb(2)

Director

Adoption(2)

8/14/2026

11/17/2026

12/31/2028

Up to 24,000 shares of common stock

Harbinger Ventures, LLC

An entity controlled by Megan Bent (Director)

Adoption

9/1/2026

12/1/2026

5/15/2027

Up to 100,000 shares of common stock

(1) Subsequent to the end of the quarter, on November 3, 2026, John Foraker terminated his Rule 10b5-1 trading arrangement described above. No shares were sold under the arrangement.

(2) Subsequent to the end of the quarter, on November 10, 2026, Walter Robb terminated his Rule 10b5-1 trading arrangement described above. No shares were sold under the arrangement.

Other than as disclosed above, no other officer, director or entity controlled by such officer or director adopted, modified or terminated a contract, instruction or written plan for the purchase or sale of securities of the Company intended to satisfy the affirmative defense of Rule 10b5-1(c) or a non-Rule 10b5-1 trading arrangement.

 

 

47


 

Item 6. Exhibits.

 

Exhibit

Number

 

Description

3.1

 

Amended and Restated Certificate of Incorporation of Once Upon a Farm, PBC (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed by the Company on February 9, 2026)

3.2

 

Bylaws of Once Upon a Farm, PBC (incorporated by reference to Exhibit 3.2 to the Current Report on Form 8-K filed by the Company on February 9, 2026)

 

31.1*

 

Certification of the Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*

 

Certification of the Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1**

 

Certification of the Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2**

 

Certification of the Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS*

 

Inline XBRL Instance Document–the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document

101.SCH*

 

Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents

104*

 

Cover page formatted as Inline XBRL and contained in Exhibit 101

 

* Filed herewith.

** This exhibit is furnished herewith and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section, and shall not be deemed to be incorporated by reference into any filing under the Securities Act or the Securities Exchange Act of 1934.

 

 

48


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Name

 

Title

 

Date

/s/ John Foraker

 

Chief Executive Officer and Chair of the Board
(
Principal Executive Officer)

 

November 12, 2026

John Foraker

/s/ Lawrence Waldman

 

Chief Financial Officer
(
Principal Financial Officer)

 

November 12, 2026

Lawrence Waldman

/s/ Chris Folena

 

Chief Accounting Officer
(
Principal Accounting Officer)

 

November 12, 2026

Chris Folena

 

49


Keep reading